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1.1. General Overview 
 
This chapter is intended to describe recent developments in 
the field of supramolecular catalysis, which has grown 
exponentially in the last few decades as indicated by the large 
number of articles present in the chemical literature.1 In 
particular, chemical transformations require making and 
breaking of chemical bonds, which not always is an easy task, 
considering that reactions require sometimes prohibitive energy 
barriers to be overcome. In these situations catalysis is a 
powerful tool because it provides the concepts necessary to 
increase reaction rate and selectivity, so it is the keystone of the 
transformation of simple chemicals into everyday life 
commodities. 
Although divided into heterogeneous catalysis and 
homogeneous catalysis, (the latter also divided into transition 
metal catalysis and organocatalysis), catalysis still remains a 
10 
multidisciplinary field linked with others such as 
supramolecular chemistry. The area at the intersection is called 
supramolecular catalysis.2 
According to this definition, catalysis is seen as a 
supramolecular phenomenon in the meaning that the catalyst 
“recognizes” the substrate, “organizes” the transition state and 
“assembles” the product. In order to create a distinction, the term 
supramolecular catalysis is referred to those reactions in which 
non covalent interactions do not take part in the rate determining 
step, but play a crucial role in determining the reaction path. In 
fact secondary interactions such as H-bond, cation-dipole, 
dipole-dipole, cation-π, π-π stacking and even Van der Waals 
and hydrophobic interactions can favor the formation of one 
enantiomer above the other in enantioselective reactions. 
Supramolecular chemists have always been inspired by 
nature’s ability of harnessing secondary interactions to achieve 
complex tasks, so it is no surprise that in the field of catalysis 
they looked at enzymes as model.3 
The conventional route, consisting in replicating the 
enzyme active site (model enzyme), sometimes proved to be 
difficult because of the structural complexity yielded by millions 
of years of evolution and natural selection. Another valuable 
11 
choice is to replicate enzyme functions without duplicating its 
structure (enzyme model or mimics) 4. 
In particular properties to borrow from enzymatic catalysis 
are substrate recognition, transition state stabilization and 
absence of product inhibition (although the last is not properly 
an enzyme characteristic). The key features necessary to get 
these properties are complementarity (of both shape and 
interactions) between catalyst and substrates, environmental 
confinement of the reactants and easy release of the products. 
The design of catalysts with the above mentioned features 
takes advantage of theories that explain how biomolecules work, 
such as lock/key and induced fit. Not only are these two concepts 
fundamental to explain how receptors specifically recognize 
substrates, but also are inspiring principles in supramolecular 
chemistry as they contributed to the development of host-guest 
chemistry. Supramolecular catalysis takes enormous advantage 
of host-guest chemistry as the idea that drove the synthesis of 
the first enzyme inspired catalysts5. 
Since then different strategies have been elaborated. One 
consists in synthesizing an artificial receptor (the host) bearing 
a catalytic moiety, in order to bring substrates (the guests) and 
12 
reactive centers in close proximity, thus increasing reaction 
rates. 
Macrocyclic compounds have proven to be excellent 
supramolecular hosts, so it is quite obvious that many 
supramolecular catalysts were based on cyclodextrines,6 
cucurbiturils,7 crown ethers,8 cavitands9 and calixarenes,10 
which from now on will be the main topic. 
 
 
1.2. Calixarenes as Supramolecular Catalysts 
 
Calix[n]arenes11 are a well-known class of macrocyclic 
compounds which have been largely exploited in the last 
decades due to their peculiar three-dimensional shape and ease 
of functionalization.12 The synthetic versatility of calixarene 
macrocycles makes them suitable for a wide range of 
applications including molecular recognition and sensing,13 
synthesis of interpenetrated architectures,14 biomolecular 
recognition,15 and catalysis.16 
13 
For example, de Mendoza and coworkers reported17 the 
synthesis of two calix[6]arene based artificial receptors (Figure 
1) able to coordinate dioctanoyl-L-α-phosphatidylcholine 
(DOPC) thanks to the complementarity with both the quaternary 
ammonium and phosphate portion of the choline. The study 




Figure 1. Structure of artificial receptors 1 and 2. 
14 
ammonium and the aromatic walls of the calixarene macrocycle, 
and the presence of three H-bonds between the phosphate and 
both the amide and guanidinium protons.  
Interactions through multiple binding sites are also 
responsible of the transition state stabilization during the 
methanolysis of p-nitrophenylcholine carbonate (PNPCC). 
Derivatives 1 and 2 catalyze the cleavage of PNPCC 
respectively 600 and 1000 times better than an equimolar 
mixture of the disconnected subunits (calixarene macrocycle 
and guanidinium alone), thus revealing the existence of a 
synergistic effect. In particular, the calixarene moiety, although 
not showing catalytic activity, contributes to stabilizing the 
transition state by interacting with the non-reactive portion of 
the substrate.  
 
 
Figure 2. Methanolysis of PNPCC 
15 
Another interesting example of artificial enzyme has been 
provided by Reinhoudt and coworkers.18  
In this case, a calix[4]arene derivative has been used as a 
scaffold to attach one, two or three α,α’-aminomethylpyridine 
 
Figure 3. Mono-, di- and trinuclear (ZnII) artificial 
phosphatases. 
16 
moieties obtaining ligands 4, 5, 6 and 7 (Figure 3). After addition 
of Zn(ClO4)2 the resulting complexes behaved as artificial, 
phosphatases in the catalytic cleavage of RNA model substrate 
2-hydroxypropyl-p-nitrophenylphosphate (HPNP). Complex 4-
[Zn] catalyzed the reaction 6 folds better than the reference 
compound 3-[Zn] thus revealing that hydrophobic effects played 
a role in the catalytic process. Dinuclear complex 5-[Zn]2 
yielded a 23000 fold rate enhancement with respect to the 
uncatalyzed reaction. This enormous result could be explained 
assuming a synergistic action of the two Zn(II) centers. 
Interestingly dinuclear complex 6-[Zn]2 was 8 times less active 
than the more flexible analogue 5-[Zn]2, showing that an 
increase in rigidity determines a decrease in the cooperativity 
between the metal ions. From this study emerged that the most 
effective catalyst is the trinuclear complex 7-[Zn]3, as a rate 
acceleration of 32000 times was observed. Compared with the 
dinuclear complex 5-[Zn]2 the additional Zn(II) center in 7-[Zn]3 
is responsible of a 40% higher rate enhancement in HPNP 
cleavage. A possible mechanism explaining these outstanding 
activity considers double Lewis acid activation of the phosphate 
by two adjacent Zn(II) centers, whereas the third metal center 
helps deprotonating the substrate by the action of a coordinated 
17 
hydroxide (Figure 4). Apart from these examples dealing with a 
binding cavity linked to a catalytic site, another approach to the 
design of supramolecular catalysts consists in a cavity able to 
bind two or more different substrates at the same time. If 
sufficient transition state stabilization (or ground state 
destabilization) is provided, then the reaction occurs even 
without catalytic moiety. Furthermore, the cavity could organize 
 
Figure 4. Proposed mechanism for HPNP cleavage by 
trinuclear phosphatase model 
18 
the reactants in such a way that the resulting product is different, 
in terms of regio- and stereoselectivity, from that commonly 
obtained. 
 
Figure 5. (a) Energy-minimized structure of the complex of 
the Rebek capsule and two toluene molecules. (b) Schematic 
representation of the Raymond tetrahedral cage. (c) Fujita 
square (left) and open-square hollow complex (right). 
19 
Pioneering studies by Rebek,19 Fujita20 and Raymond21 
demonstrated that self-assembled hosts could be very useful in 
this kind of catalysis (Figure 5). For example Rebek non-
covalent capsule catalyzed dipolar addiction, while Fujita square 
and open-square hollow containers favored Diels Alder reaction. 
Raymond reported tetrahedral metal-ligand cage able to catalyze 
acid hydrolysis of orthoformate even in basic media. 
Calixarenes also proved to be suitable scaffolds for the 
synthesis of container molecules to harvest several trademark 
features of enzymatic catalysis. Wang and coworkers22 reported 
the formation of container 8 after reaction of p-tert-
butylsulfonylcalix[4]arene, Co(II) or Ni(II) and a linker such as 
 
Figure 6. Assembly of supercontainer 8. 
20 
4,4’-methylenedibenzoic acid (Figure 6). Screening of the 
catalytic activity of 8 for the Knoevenagel condensation 
involving the nucleophilic addition of malononitrile to aromatic 
aldehydes highlighted an interesting feature. Among all the 
substrate tested the only fair yield (67%) was obtained with 
sterically demanding 1-pyrenecarboxaldehyde. According to the 
authors this outstanding reactivity can be rationalized on the 
basis of a lock-and-key type match between 8 and 1-
 
Figure 7. Proposed mechanism for the Knoevenagel condensation 
catalyzed by 8. 
21 
pyrenecarboxaldehyde. The relatively weak Brønsted acidity of 
the μ4-H2O means that 8 does not readily protonate and activate 
an aldehyde unless the substrate possesses a suitable molecular 
size and shape to fit inside the cavity and allows its aldehyde 
moiety to be preorganized within the close proximity of the 
active site. Moreover, the final alkenyl product is easily released 
from the cavity because of its bulkiness, thus avoiding product 
inhibition (Figure 7). 
All these examples so far discussed show the versatility of 
calixarene macrocycles in the design of supramolecular 
catalysts. In fact they could be used both as scaffolds to attach 
catalytic moieties (as artificial receptors 1 and 2, and ligands 4-
7) and as building blocks in the self-assembly of supramolecular 
cages (as supercontainer 8). Another important feature is the 
variety of reactions calixarene derivatives can catalyze. They 
could act as enzyme mimics in the strict sense, behaving as 
hydrolases and phosphatases acting on their substrate (like 
PNPCC and HPNP), but the resemblance with enzymes could 
also be interpreted in a more general way, as in the last example, 
where the concept of enzyme mimics is applied to a common 




























Given examples described above, our aim was to explore 
the role that calixarene cavities could play in determining the 
outcome of common chemical reactions. In order to do that, we 
synthesized new calix[4]arene derivatives 9-16 (Figure 8a-b), 
functionalized at their lower or upper rim with chiral catalytic 
moieties, and calix[8]arene zirconium complex 17(Zr-O-tBu)2 
(Figure 8c). Compounds 9-15 proved to be good Na+ 
complexing agents, thanks to the amide pendants, so they have 
been tested in asymmetric phase transfer alkylation reactions 
thanks to a collaboration with the group of Dr. Della Sala (see 
Chapter 3).23 Derivative 16, bearing a thiourea and a primary 
amine, has the typical design of bifunctional catalysts, therefore 
has been tested in Michael type reactions between carbonyl 
nucleophiles and activated alkenes, in collaboration with the 
group of Prof. Lattanzi (see Chapter 4).24 Since our interests did 
not confine to organocatalysis, we decided to start a 
collaboration with Prof. Grassi research group, involving the 
26 
synthesis and characterization of complex 17 (Zr-O-tBu)2 and 
the evaluation of its activity in the ring opening polymerization 
of cyclic esters (see Chapter 5).25 
 
 
Figure 8. (a) Phase Transfer Catalysts 9-15. (b) Bifunctional 

























3.1. General Overview 
 
During last decades phase-transfer catalysis,26 requiring 
simple procedures, mild reaction conditions and providing large 
scale synthesis, has emerged as a powerful protocol in those 
fields where green chemistry standards are required, such as 
food or pharmaceutical industry. 
The reaction between the species situated in two distinct and 
immiscible phases (generally an organic and an aqueous, or 
solid, one) occurs thanks to compounds with a good affinity for 
both media, such as quaternary ammonium ions, able to operate 
the transfer of the reactants from a phase to another (phase-
transfer catalyst, PTC). 
Thanks to their aromatic cavity and to the tert-butyl groups, 
calixarenes show hydrophobic character, but it is possible to 
enhance hydrophilicity by functionalization with ionic moieties, 
so that amphyphylic calixarene based PTC have been 
30 
developed.27 In these cases the macrocycle acts as a scaffold 
bearing quaternary ammonium groups as the actual phase-
transfer catalysts, thus ignoring calixarenes properties as 
supramolecular hosts. 
It has long been known the high affinity that calix[4]arene-
amide hosts display towards alkali metal cations. The studies 
conducted by Arnaud-Neu and coworkers28 showed that Na+ 
was the best extracted cation, among the alkali metal cations 
series (Figure 9a).29  
These cation-recognition abilities of calixarene-amides have 
been particularly exploited in sensing devices29a,c-e for the 
detection of metal ions and for the extraction of alkali picrates,28 
 
 
Figure 9. (a) Complexation of Na+ with calix[4]arene-
tetramide hosts. (b) The first example of calix[4]arene-based 
PTC. 
31 
whereas their employment in phase transfer catalysis has 
surprisingly remained elusive. 
Shinkai30 (Figure 9b) and Taniguchi31 reported about thirty 
years ago some examples of PTC exploiting the cation-
 
Figure 10. Calixarene based PTC proposed by (a) Sirit, (b) 
Su, (c) Shimizu. 
32 
recognition abilities of calixarene-ether derivatives. Since then, 
however, this strategy has been completely disregarded.32 
Although calix[4]arene-tetraamides are better hosts for alkali-
metal cations than calixarene-ethers, their employment in the 
field of phase-transfer catalysis has been inexplicably 
uninvestigated. The development of enantioselective reactions 
using a PTC protocol is a task of great importance because of 
the possibility to obtain optically active molecules of biological 
and pharmaceutical interest.33 In this regard, the synthesis of 
optically active α-amino acids via phase transfer alkylation of 
prochiral protected glycine derivatives with chiral calixarene-
ammonium catalysts has been studied in the last decade. Thus, 
Sirit34 and co-workers designed a chiral calix[4]arene, bearing at 
the lower rim two ammonium pendant groups derived from 
cinchona alkaloid, as a phase–transfer catalyst for the 
enantioselective synthesis of α-amino acids. Analogously, Su35 
and Shimizu36 reported calix[4]arene-based phase-transfer 
catalysts, bearing cationic pendant groups at the lower and the 
upper rim respectively, for the enantioselective α-
functionalization of glycine. Surprisingly, no examples of 
asymmetric phase-transfer catalysis exploiting the cation-
33 
recognition abilities of chiral calixarene-amide hosts have been 
reported to date. 
Prompted by these considerations we designed chiral 
calix[4]arene-amides 9-15 (Figure 11) and we wish to report 
here on their abilities as phase-transfer catalysts in the 
asymmetric alkylation of N-(diphenylmethylene)-glycine esters. 
 
 
3.2. Synthesis of new PTC Calixarene-Based Catalysts. 
 
Calixarene-amide derivatives 9 and 10 were synthesized 
according to the procedures reported by Stibor and coworkers.37 
Figure 11. Calix[4]arene amides 9-15. 
34 
Calixarene-monohydroxy-triamide 11 was obtained following 
the procedure reported in figure 12a. In details, the known 
calix[4]arene-tri-carboxylic acid  1738 was converted into the 
corresponding acyl chloride and then coupled with (S)-α-
methylbenzylamine to give 11 in 20 % yield, which was 
characterized by HR ESI(+)-MS, 1H and 13C NMR spectroscopy 
(see experimental section). 
Calixarene-monomethoxy-triamide 12 was obtained 
following a synthetic route similar to 11 (Figure 12a). The 
methylation of the free OH group of 16 in the presence of 
potassium carbonate afforded 25-methoxy-26,27,28-tris-
((ethoxycarbonyl)methoxy)-5,11,17,23-tetra-tert-butyl-
calix[4]arene 1839 in 70 % yield. Derivative 18 was suspended 
in a mixture of EtOH/H2O and hydrolyzed in the presence of 
NaOH to give triacid 19 in 96 % yield, which was first converted 
into the corresponding acyl chloride, then coupled with (S)-α-
methylbenzylamine to give 12 in 57 % yield. 
The synthesis of calix-dimethoxy-diamide 13 is outlined in 
Figure 12b.  The known diacid derivative 2040 was converted 
into the corresponding diacyl chloride and then directly coupled 
with (S)-α-methylbenzylamine to give 13 in 80 % yield, which 
was characterized by HR ESI(+)-MS, 1H and 13C NMR 
35 
spectroscopy.(see experimental section) Calix-trimethoxy-
monoamide 14 was easily obtained (Figure 12c) transforming 
the known monoacid derivative 2141 into the corresponding acyl 
chloride by treatment with oxalyl chloride, and subsequent 
coupling with (S)-α-methylbenzylamine to give 14 in 60 % 
yield. Finally, calix-monomethoxy-naphthyl-triamide 15 was 
obtained in 76 % yield, by coupling the acyl chloride of 19 




Figure 12. Synthesis of derivatives 11-15. Conditions a): dry CH2Cl2, dry NEt3, (S)-α-
methylbenzylamine, 15 h, room temperature. Conditions b): dry CH2Cl2, dry NEt3,  (S)-1-(2-
naphthyl)ethylamine, 3 d (63 h), room temperature. 
37 
3.3. Asymmetric PTC Catalysis. 
 
Thanks to a collaboration with Prof. I. Izzo, Dr. G. Della 
Sala and Dr. R. Schettini, calix[4]arene-amides 9-15 were tested 
in the phase-transfer alkylation of N-(diphenylmethylene)-
glycine tert-butyl ester 22 with benzyl bromide in a liquid-liquid 
system NaOH 50%/toluene at 0 °C, with a catalyst loading of 5 
mol % (Table 1, entries 1-7). The alkylation catalyzed by 
tetramide 9 led to the (R)-benzylated product 23a with a good 
yield but with disappointing enantioselectivity (Table 1, entry 
1). Comparable yields and faster reactions were obtained with 
amides 10 and 11, but the resulting enantioselectivities were 
even lower (Table 1, entries 2 and 3), probably due to the 
undesired alkylation of the hydroxyl of 10 and 11. 
To avoid the side reaction, we focused on calix-methoxy-
amides 12-14. A significant improvement of both yield and 
enantioselectivity was achieved with triamide 12 (Table 1, entry 
4). The enantioselectivity decreased when reducing the number 
of chiral amide moieties (entries 5 and 6), as monoamide 14, led 
to racemic product and incomplete conversion even after 20 h. 
A possible explanation is that in this case, the presence of only 
one chiral amide group results in reduced cation-complexing 
38 
abilities, while synergistic action of two or three amide pendants 
increases stereodifferentiating abilities. Using compound 15, 
functionalized with (S)-α-methylnapthylamine pendants, in 
place of (S)-α-methylbenzylamine, slowed down the reaction 
and led to lower ee value (Table 1, entry 7), due to excessive 
steric hindrance, that probably results in reduced access to the 
catalytic site. A comparison of the yields obtained in the 
presence of calixarene-amides 9-15 with the low conversion 
Figure 13. Phase-transfer benzylation of N-
(diphenylmethylene)-glycine t-butyl ester 22 catalyzed by 
amide 24 and calixarene-tetramide 25. 
39 
observed in the uncatalyzed reaction (8% yield after 24 h, Figure 
13a) confirmed the catalytic activity of these macrocycles. 
Table 1. Phase-transfer benzylation of N-




Entry Catalyst Substrate Time [h] Yield[b] [%] ee[c,d] [%] 
1 9 t-Bu– (22) 20 77 13 
2 10 t-Bu– (22) 4 71 7 
3 11 t-Bu– (22) 4 83 5 
4 12 t-Bu– (22) 5 92 28 
5 13 t-Bu– (22) 4 92 13 
6 14 t-Bu– (22) 20 48 rac 
7 15 t-Bu– (22) 20 97 9 
8 12 Et– (26) 3 77 4 
9 12 Bn– (27) 7 80 rac 
10 12 Ph(Me)2C– (28) 6 84 24 
11 12 Ph2CH– (29) 5 74 6 (S) 
[a] All reactions were performed in a liquid-liquid system with 0.08 mmol of 
substrate 22,26-29, benzyl bromide (1.2 equiv.), and catalyst (5 mol %) in 
toluene (0.8 mL) and NaOH 50% aq (0.5 mL). [b] Isolated yields. [c] 
Determined by HPLC using a Chiralcel OD-H chiral stationary phase. [d] The 
absolute configuration of the products were determined by comparison of the 
HPLC retention times and optical rotations with literature values.34,,42 
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In order to prove the effect of calixarene scaffold on 
catalytic activity and enantioselectivity, we conducted the 
reaction in the presence of chiral monoamide 24 (0.20 equiv., 
Figure 13b). Racemic benzylated product 23a was obtained in 
9% yield, presumably as a result of the background reaction. The 
achiral tetramide 25, athough less active than its chiral analogue 
9, also showed a moderate catalytic activity (5 mol% cat., 40 % 
yield, Figure 13c). We assumed that the calixarene scaffold 
plays an essential role in phase-transfer catalysis activity by 
preorganizing and orienting properly the amide groups in such a 
way as to favor the complexation of Na+ cation. 
Successively, we evaluated the effect of the ester group in 
the substrate, using the best catalyst 12. As expected,42 the 
presence of less hindered ester groups, such as ethyl and benzyl, 
reduced the stereoselectivity of alkylation (Table 1, entries 8 and 
9). Cumyl ester 28 afforded lower ee (Table 1, entry 10). A 
disappointing result was also observed with the benzhydryl ester 
29, with an unexpected inversion of enantioselectivity (Table 1, 
entry 11). 
After screening of the catalysts and the ester groups of the 
substrates, we directed our attention towards examining the 
41 
 
Table 2. Optimization of phase-transfer benzylation of 22 
promoted by calix[4]arene-triamide 12.[a] 
 
















































6 89 26 
11 mesitylene NaOH (s) 92 75 4 (S) 
12 mesitylene KOH 50% aq. 92 76 10 (S) 
13 mesitylene KOH (s) 44 79 15 (S) 
14 mesitylene CsOH (s) 44 72 11 (S) 
15 [e] mesitylene 
NaOH 50% 
aq. 
92 12 14 
16 [f] mesitylene 
NaOH 50% 
aq. 
7 73 28 
17 [g] mesitylene 
NaOH 50% 
aq. 
20 73 13 
[a] Reactions were performed in a liquid-liquid system with 0.08 mmol of 22, 
benzyl bromide (1.2 equiv.), and catalyst (5 mol %) in toluene (0.8 mL) and 
NaOH 50% aq (0.5 mL), except where otherwise noted. [b] Isolated yields. [c] 
Determined by HPLC using a Chiralcel OD-H chiral stationary phase. [d] The 
absolute configuration of the product was determined by comparison of the 
HPLC retention time and optical rotation with literature values.42 [e] Reaction 
performed at -20°C. [f] 10 mol % of catalyst loading was used. [g] 2.5 mol % 
of catalyst loading was used. 
 
42 
effect of other parameters, such as solvent, base, catalyst 
loading, and temperature, on the benzylation of t-butyl ester 22 
promoted by 12. Good yields but poor enantioselectivities were 
obtained in different reaction media such as chlorinated 
solvents, ether, chlorobenzene, and xylenes (Table 2, entries 2-
8). On the other hand, a significant improvement, up to 35% ee, 
was obtained in mesitylene (Table 2, entry 9), while adding a 
10% amount of CH2Cl2. in mesitylene resulted in lower ee 
(Table 2, entry 10). The use of inorganic bases other than 
aqueous NaOH 50% resulted in low values and a startling 
inversion of the enantioselectivity (Table 2, entries 11-14). 
Replacement of sodium with the larger potassium or cesium 
cation, determines a change in the host-guest interactions that 
lead to a different tridimensional structure. This may affect the 
mode of association with the carbanion and hence 
enantioselectivity. At -20°C the reaction proceeded slowly, 
resulting in low conversion and enantioselectivity, even after 
prolonged reaction time (Table 2, entry 15). Lower 
enantioselectivities were also obtained with smaller or higher 
catalyst loadings (Table 2, entries 16 and 17). While examples 
of reduced enantioselectivity with increasing amount of catalyst 
has been frequently described,43 much less common is the 
43 
opposite effect.44 Presumably, at higher concentrations, 
aggregation of the host-guest complex is responsible of the low 
enantioselectivity. 
Finally, we carried out this calix[4]arene-amide catalyzed 
reaction with other alkylating agents, under optimized 
conditions (NaOH 50% aq., 5 mol. % of triamide 12, in 
mesitylene, Table 3). Good yields of alkylated products were 
obtained in all cases. Higher enantioselectivities were achieved 
Table 3. Phase-transfer alkylation of 22 promoted by 
calix[4]arene-triamide 12.[a] 
 
Entry R Product Time [h] Yield
[b] [%] ee[c,d] [%] 
1 benzyl 23a 7 86 35 
2 4-methylbenzyl 23b 7 85 47 
3 4-(t-butyl)benzyl 23c 20 79 44 
4 2-methylbenzyl 23d 7 75 15 
5 [e] allyl 23e 20 75 15 
[a] All reactions were performed in a liquid-liquid system with 0.08 mmol of 22, 
benzyl bromide (1.2 equiv.), and catalyst (5 mol %) in toluene (0.8 mL) and 
NaOH 50% aq (0.5 mL). [b] Isolated yields. [c] Determined by HPLC using a 
Chiralcel OD-H chiral stationary phase. [d] The absolute configuration of the 
product was determined by comparison of the HPLC retention time and optical 
rotation with literature values.42 [e] 1.5 equiv. of allyl bromide were used. 
 
44 
with p-alkyl substituted benzyl substrates (Table 3, entries 2 and 
3), whereas with a ortho-substituted substrate and with allyl 
bromide a 15% ee resulted (Table 3, entries 4 and 5). 
 
 
3.4. Recognition Abilities of Calix[4]arene-Amides toward Na+ 
Cation. 
The complexation of Na+ by calix[4]arene-amide catalyst is 
the fundamental step in the phase-transfer alkylation of glycine 
ester 22 with benzyl bromide (Tables 1-3), so we decided to 
investigate the recognition abilities of the most active 
calix[4]arene-amides catalysts 9, 12, 13, 15 toward Na+ guest. 
1H NMR titration experiments45 of a CDCl3 solution of host with 
NaTFPB [tetrakis[3,5-bis(trifluoromethyl)phenyl]borate]46 
were performed. The choice of this particular sodium salt resides 
in the fact that hydrophobic TFPB−, that is known to be a weakly 
coordinating anion,47 confers relatively good solubility to its 
sodium salt in organic solvents,48 thus allowing to determinate 
the apparent association constant of the complex by direct 
integration of its 1H NMR signals with respect to those of the 
free host. 
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The first host under investigation was tetraamide 9. From a 
qualitative point of view, we could affirm that a host/guest 
complex is formed because the 1H NMR spectrum of 9 recorded 
at room temperature in CDCl3 (Figure 14a) drastically changes 
Figure 14. Expansion of the 1H NMR spectra (400 MHz, 
CDCl3, 298 K) of: (a) tetramide 9 (1.9 mM) (b) a mixture of 
9 (1.0 equiv., 1.9 mM) and NaTFPB (0.5 equiv., 0.95 mM)  
after mixing; (c) an equimolar solution (1.9 mM) of 9 and 
NaTFPB after equilibration for 3 d at 298 K. 
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after addition of NaTFPB. The addition of 0.5 equiv of NaTFPB 
results in the appearance of new signals (Figure 14b). In details, 
it is possible to individuate a new AX system (4.25 and 3.26 
ppm, J = 12.0 Hz) in the 1H NMR spectrum (in red in figure 
14b), attributable to the ArCH2Ar groups of the Na
+⸦9 complex 
in slow exchange with those of the free host 9 on the NMR time 
scale. The OCH2 protons of the free host 9, resonating at 4.33 
ppm (AB system), form a new AX system (4.52 and 3.89 ppm, 
J = 13.2 Hz) after complexation with Na+ (in magenta in figure 
14b). After a further addition of 0.5 equiv of NaTFPB the system 
was equilibrated for 3 days at 25 °C and a 74% yield of the 
Na+⸦9 complex was calculated by 1H NMR signal integration 
of both complexed and free host 9 (Figure 14c). From the 
percentage of formation of the Na+⸦9 complex an apparent 
association constant (Ka) of 1.22±0.04×10
4 M-1 was calculated. 
Successively, we studied the binding affinity of calixarene-
monomethoxy-triamide 12 toward NaTFPB in CDCl3 (Figure 
15). Structure elucidation of free 12 was made by 1D and 2D 
NMR spectroscopy. 1H NMR spectrum (CDCl3, 298 K) of 
compound 12 (Figure 15a) displays four AX systems at 
4.49/3.24, 4.31/2.94, 4.11/3.24, and 4.08/3.24 ppm (COSY 
spectrum, see experimental section) which correlate in the 
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HSQC spectrum with CH2 carbon signals at 31.6, 31.5, and 31.8 
(x2) ppm, respectively. By the known Gutsche's and de 
Mendoza's rules,49 these data were only compatible with a cone 
 
Figure 15. 1H NMR spectra (400 MHz, CDCl3, 298 K) of: 
(a) triamide 12 (1.9 mM) (b) an equimolar solution (1.9 mM) 
of 12 and NaTFPB after mixing; (c) an equimolar solution 
(1.9 mM) of 12 and NaTFPB after equilibration for 3 d (72 
h) at 298 K. 
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conformation of 12. An important information about the 
peculiarity of the cone conformation adopted by 12, is given by 
the presence in the 1H NMR spectrum of shielded aromatic 
signals in the 6.40-6.47 ppm region (integrating for 4 H). This is 
an evidence of the fact that the calixarene skeleton of 12 adopts 
a pinched conformation. The pinched-cone conformation 
adopted by 12 in solution was studied by DFT calculations at the 
B3LYP/6-31G(d,p) level of theory, highlighting the presence of 
two stabilizing intramolecular H-bonding interactions between 
amide groups at the lower rim. 
The addition of 0.5 equiv. of NaTFPB salt to a CDCl3 
solution of 12 resulted in the appearance of a new set of signals 
in the 1H NMR spectrum attributable to the formation of the 
Na+⸦12 complex, which was in slow exchange with free 12 on 
the NMR time scale (Figure 15b). Further addition of 0.5 
equivalents of NaTFPB salt and equilibration for 3 days at 25° 
C quantitatively afforded Na+⸦12 (Figure 15c). 
After determining the 1:1 stoichiometry of the Na+⸦12 
complex by spectral integration (with respect to the TFPB−ArH 
signal), structure elucidation was made by means of 1D and 2D 
NMR studies (2D HSQC and COSY spectra; 600 MHz, CDCl3; 
see experimental section). In details, the disappearance in the 1H 
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NMR spectrum of the signals of 12 between 6.40-6.47 ppm, 
which are attributable to the aromatic rings of the pinched-cone 
inwardly oriented with respect to the calix-cavity, reveals that 
Na+ complexation determines a conformational change of 12 
from the pinched-cone to a “classic” cone conformation, in 
which the above mentioned aromatic protons resonate between 
7.01 and 7.39 ppm. This conformational shift is probably due to 
the fact that Na+ complexation occurs thanks to cation dipole 
interactions with the oxygens at the lower rim, determining the 
encapsulation of the cation and disrupting hydrogen bonds 
between amide groups that stabilized the pinched-cone 
conformation. Thus, the 1H NMR signals attributable to the 
OCH2 groups at the lower rim of 12 are downfield shifted in the 
Na+⸦12 as a consequence of the cation proximity. On the other 
hand, the singlet at 3.74 ppm attributable to the OCH3 group of 
12 is upfield shifted at 3.65 ppm. This quite surprising result can 
be explained by a close inspection of the DFT-optimized 
structure of the Na+⸦12 complex at the B3LYP/6-31G(d,p) 
theory level, that indicates that the OCH3 group is in close 
proximity to a phenyl ring, thus establish a C-H···π interaction, 
with a C-H···πcentroid distance of 2.81 Å (Figure 16*). This 
result fully elucidate the different trend observed for OMe signal 
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with respect to OCH2 groups at the lower rim of 12 after Na
+ 
complexation. 
In a similar way, addition of 0.5 equiv. of NaTFPB to a 
CDCl3 solution of naphthyl-triamide 15, resulted in the 
appearance of a new set of signals. In particular, four new AX 
systems are displayed (4.04 and 3.19 ppm, J = 11.8 Hz; 4.14 and 
3.30 ppm, J = 11.8 Hz; 4.17 and 3.37 ppm, J = 12.4 Hz; 4.21 and 
3.22 ppm, J = 12.0 Hz) which were attributable to ArCH2Ar 
 
Figure 16. DFT-optimized structures of free 12, in the 
pinched-cone conformation, and Na+12 complex at the 
B3LYP/6-31G(d,p) theory level (some H atoms have been 
omitted for clarity). Dotted lines in yellow indicate 
intramolecular H-bonds stabilizing the pinched conformation 
(average N-H···O=C distance 2.87 Å). Inset (*): particular of 
the C-H···π interaction between methyl group and phenyl 
ring in the Na+12 complex. 
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groups of Na+⸦15 complex in slow exchange on the NMR time 
scale. In addition, three AX systems were individuated (4.33 and 
3.85 ppm, J = 14.8 Hz; 4.37 and 4.05 ppm, J = 11.6 Hz and 4.60 
and 4.44 ppm, J = 13.6 Hz) due to the OCH2 groups of Na
+⸦15 
complex. Finally, the OCH3 group was present as a singlet at 
3.60 ppm. Upon a further addition of 0.5 equivalents of NaTFPB 
salt, the formation of the Na+⸦15 complex was complete after 
equilibration for 3 days at 25 °C. A percentage of formation of 
78 % was calculated by integration of the OCH3 singlets for free 
and complexed 15, which gave an apparent association constant 
(Ka) of 9.16±0.04×10
3 M−1 (see experimental section). 
Direct signal integration wasn’t suitable for determining the 
apparent association constant of the Na+⸦12 complex because 
the intensities of the 1H NMR signals (Figure 15c) of the free 
host 12 were below the reliable 10 % limit. Therefore, Ka was 
calculated by means of a competition experiment45 between 
hosts 12 and 15. A 1:1:1 mixture of 12, 15 and NaTFPB 
equilibrated for 3 days at 25 °C, afforded Na+⸦12 and 
Na+⸦15complexes with a percentage of formation of 56 and 
44%, respectively, from which, an apparent association constant 
of 1.26±0.09×104 M−1 was calculated for the formation of 
Na+⸦12 complex (see experimental section). 
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Finally, we investigated the binding abilities of host 13. In 
order to elucidate the structure of free 13 we recurred to VT 1H 
NMR studies. In fact, 1H NMR spectrum of calix-dimethoxy-
diamide 13 recorded at ‒ 40 °C shows an AX system at 4.12 and 
3.20 ppm, due to the resonance of the ArCH2Ar groups, which 
correlates in the 2D HSQC spectrum with a signal at 31.2 ppm.  
From the known Gutsche's and de Mendoza's rules,49 these data 
were only compatible with a cone conformation of 13. Na+⸦13 
complex formed after adding 1 equiv. of NaTFPB to a CDCl3 
solution of 13 at 25 °C, as proved by the emerging, in the 1H 
NMR spectrum, of new set of slowly exchanging signals. In 
depth study of the NaTFPB/13 mixture by mean of 1D and 2D 
NMR spectra revealed that calix[4]arene-diamide 13 can bind 
Na+ adopting two different conformations (Figure 17). In details, 
four doublets were present at 4.06, 3.95, 3.33, and 3.31 ppm 
which correlated with carbon resonances at 29.8 and 30.0 ppm, 
attributable to ArCH2Ar groups between syn oriented Ar-rings, 
and compatible with a calixarene in a cone conformation 
(Na+⸦13cone). Moreover, the corresponding OCH2 resonate at 
4.52 and 4.40 ppm, while the OCH3 singlet was present at 3.52 
ppm. Besides, 1D and 2D NMR spectra allowed to individuate 
and characterize a Na+⸦13 complex in which the calixarene 
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adopts a partial-cone conformation (Na+⸦13paco). In fact, two 
AB systems at 3.76 and 3.82 ppm, which correlated in the HSQC 
spectrum with carbon atoms resonating at 37.5 and 37.9 ppm, 
were characteristic of methylene groups between anti oriented 
Ar-rings. In addition, two AB systems attributable to OCH2 
groups were detected at 4.51/4.26 and 4.60/4.28 ppm. Finally, 
two singlets, attributable to the lower rim and inverted OCH3 
group of the Na+⸦13paco complex resonated at 3.30 and 1.97 
ppm, respectively. 
 
Figure 17. Expansion of the 1H NMR spectra (400 MHz, 
CDCl3, 298 K) of: (a) derivative 13 (1.9 mM) (b) an 
equimolar solution (1.9 mM) of 13 and NaTFPB after 
equilibration for 3 d at 298 K. 
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Calix[4]arene-amides 9, 12, and 15 showed good 
complexing ability toward Na+ cation, thus explicating their 
activity as PTC. A possible mechanism for the asymmetric 
phase-transfer alkylation of 22 consider the interfacial formation 
of a tight ion pair between Na+⸦calixarene-amide complex and 
the enolate anion generated after deprotonation of 22. The chiral 
lipophilic ion pair can diffuse into the organic layer and undergo 
enantioselective alkylation. 
This study constitutes a valuable application of host-guest 
chemistry to catalysis, as, for the first time, calix[4]arene-amides 
9-15 turned out to be active in the phase-transfer alkylation of 
N-(diphenylmethylene)glycine esters, thanks to their 
complexing properties. In depth investigation of the cation 
binding abilities of compounds 9, 12, 13 and 15 was performed, 
in order to elucidate their catalytic activity. Apparent association 
constants determined for catalysts 9, 12, 15 using NaTPB guest 
confirmed the importance of efficient Na+ complexation in order 
to reach high performances. Our hope is that these results could 
focus the attention on calixarenes modified with complexing 








































4.1. General Overview 
 
Asymmetric organocatalysis consists in the use of small 
optically pure organic molecules in order to favor the formation 
of an enantiomer above the other during a reaction. 
 
Figure 18. (a) Aldol reaction catalyzed by L-proline. (b) 
Diels-Alder reaction promoted by MacMillan catalyst. 
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This discipline aroused in the early 2000 when List and 
Barbas discovered that the aldol reaction of acetone and a series 
of aldehydes in presence of L-proline yielded β-hydroxyl-
ketones with high enantioselectivities (Figure 18a),50 and 
MacMillan reported a phenylalanine derived imidazolidinone 
promoting enantioselective Diels-Alder reactions (Figure 
18b).51 
These pioneering works paved the way to the flourishing of 
aminocatalysis,52 a branch of organocatalysis characterized by 
the fact that reactions are promoted by primary or secondary 
amines, which activate the reactants by means of covalent bond 
formation (Figure 19). According to this mechanism, an 
aminocatalyst could activate a carbonyl compound either by 
enhancing its electrophilic or nucleophilic character via 
formation of an iminium or enamine intermediate, respectively. 
 
 
Figure 19. Substrate activation via covalent bond formation. 
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In more recent years a novel class of organocatalysts have 
been proposed, called bifunctional organocatalysts.53 Their 
feature is the presence of a Brønsted acidic moiety in addition to 
an amine function, attached to a chiral scaffold. This trait allows 
simultaneous activation of both nucleophile and electrophile via 
general acid-base catalysis. If the catalyst combine a primary 
amine and a urea or thiourea as the acidic moiety, then is 
possible to combine nucleophile activation via enamine 
formation and electrophile activation via hydrogen bond: the 
generation of a rigid transition state is responsible of the high 
selectivities obtained (Figure 20).54 
 
Figure 20. Asymmetric Michael addition of acetone to 
aromatic nitroolefins promoted by a primary amine thiourea 
bifunctional organocatalyst. 
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An interesting perspective consists in combining a 
bifunctional catalyst and a calixarene macrocycle in order to 
 
Figure 21. Catalytic addition of isobutyraldehyde to (a) N-
phenylmaleimide and (b) p-methyl-trans-β-nitrostyrene.  
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have an additional site for substrate recognition not involved in 
the catalytic process. 
To the best of our knowledge the only example of such a 
compound has been reported by Sirit and Durmaz in the 
asymmetric Michael reactions of α,α-disubstituted aldehydes 
with maleimides (Figure 21a) and nitroolefins55 (Figure 21b). 
The study outlined that compound 30 promotes the conjugate 
addition of a series of branched aldehydes to maleimide or 
nitroolefins in CH2Cl2 at room temperature with high yield and 
enantiomeric excesses. Anyway the trans-1,2-
diaminocyclohexane moiety is known to be itself an excellent 
bifunctional catalyst and its distance from the calixarene 
macrocycle raise doubts about the cavity involvement in the 
 
Figure 22. Bifunctional organocatalysts 16 and 31. 
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transition state. Moreover catalysis by compound 30 is not a 
green process for two reasons: one is the solvent used (CH2Cl2), 
the other is the fact that to a certain catalyst loading actually 
corresponds a double amount of chiral amine. 
Prompted by these considerations we designed calix[4]arene 
16 bearing the chiral primary amine, thiourea moiety at the upper 
rim, in close proximity to the cavity (Figure 22). Derivative 16 
has then been tested in the conjugate addition of carbonyl 
nucleophiles (isobutyraldehyde and dimethyl malonate) to 
activated alkenes (N-phenylmaleimide, trans-β-nitroolefins and 
benzylideneacetone), exploiting enamine and iminium 
activation strategies. In order to prove the effect of the calixarene 
cavity the catalytic activity of compound 16 has been compared 
to that of non-macrocyclic compound 3156 (Figure 22). 
 
 
4.2. Synthesis of new Bifunctional Organocatalysts 
 
Derivatives 16 and 31a have been synthesized as outlined in 
Figure 23. Compound 16 has been prepared treating known 
mono amino derivative 3257 with thiophosgene in refluxing 
toluene for two hours. Resulting isothiocyanate 3357 is used 
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without purification in the coupling reaction with the known 
mono protected trans-(R,R)-1,2-diaminocyclohexane derivative 
3458 in dry CH2Cl2 at room temperature, obtaining compound 35 
in 60% yield after column chromatography. Compound 35 has 
been characterized by HR ESI(+)-MS, 1H and 13C NMR 
spectroscopy. Compound 35 has then been heated in refluxing 
ethanol in presence of NH2NH2 thus obtaining compound 16 
after precipitation from CH3CN in 52% yield. Compound 16 has 
been characterized by HR ESI(+)-MS, 1H and 13C NMR 
spectroscopy (see experimental section). 
 
 
Figure 23. Synthetic Scheme of compounds 16 and 31a. 
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Similarly compound 31a has been prepared starting from 4-
methoxyaniline 36, which was converted into the corresponding 
isothiocyanate 37 and then reacted with compound 34 to give 
thiourea derivative 38. Deprotection of 38 with NH2NH2 in 
refluxing ethanol gave 31a in 76% yield. Compound 31a has 




4.3. Asymmetric Conjugate Addition 
 
A collaboration with Prof. A. Lattanzi and Dr. S. Meninno 
highlighted the catalytic properties of derivative 16. 
Initially derivative 16 has been tested in the Michael 
addition of isobutyraldehyde (2 equiv.) to N-phenylmaleimide 
in a CHCl3/H2O system using a catalyst loading of 15 mol%, and 
compared to the literature data54c (Table 4, entries 1, 2, 3). Under 
these conditions, (R)-2-(2,5-dioxo-1-phenylpyrrolidin-3-yl)-2-
methylpropanal59 39 was obtained in 50% yield and 94% 
enantiomeric excess after 50 minutes at room temperature 
(Table 4, entry 1). Although less active than 31b and 31c, 16 
performed comparable enantioselctivity. This promising result 
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prompted us to investigate different reaction media. Instead of a 
screening of different solvents, we preferred greener alternatives 
such as “on water”60 and solvent free conditions (Table 1, entries 
4, 5). Using water as the reaction media led to highly increased 
product yield, but enantioselectivity decreased. A possible 
explanation is that hydrophobic interactions forces the reactants 
Table 4. Catalytic enantioselective Michael reaction of 
isobutyraldehyde with maleimide. 
 
Entry Catalyst Solvent Time 
[min] 
Yield[b] [%] ee[c,d] [%] 
1
[a]
 16 CHCl3 





H2O (15 mol%) 
40 93 97 
3 31c 
CHCl3 
H2O (15 mol%) 
40 96 94 
4 16 H2O 80 98 77 
5 16 - 30 98 88 
6 31a - 30 98 72 
[a] reaction  performed using 2 equiv. of isobutyrhaldeyde. [b] Isolated yields. 
[c] Determined by HPLC using a Chiralcel OD-H chiral stationary phase. [d] 
The absolute configuration of the products were determined by comparison of 
the HPLC retention times and optical rotations with literature values.54c,,59 
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in close proximity thus enhancing hydrogen bond between the 
thiourea moiety of 16 and N-phenylmaleimide, making the 
substrate more electrophilic.61 On the other hand water hinders 
formation of the enamine intermediate between the primary 
amine of 16 and isobutyraldehyde, which is responsible of the 
tight transition state and the resulting enantioselectivity. 
Consequently, an alternative non covalent pathway via enolate 
would occur, likely proceeding with lower enantiocontrol. 
Solvent free conditions (Table 4, entry 5) combine excellent 
reactivity (98% yield after 30 minutes), due to reactants 
aggregation, and good enantioselectivity (88% ee), due to 
efficient formation of enamine intermediate. To evaluate the role 
of the calixarene scaffold on catalytic activity and 
enantioselectivity a solvent free reaction of isobutyraldehyde 
and N-phenylmaleimide in presence of derivative 31a was 
performed (Table 4, entry 6). Compound 39 was obtained after 
30 minutes in 98% yield and 72% ee, thus demonstrating that, 
although not playing any role in activating the substrates, the 
macrocycle contributes in organizing the transition state. 
Encouraged by results shown in table 4, we decided to 
extend the scope of possible Michael acceptors to trans-β-
nitroolefins. The optimized reactions conditions (4 equiv. of 
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aldehyde, solvent free, catalyst loading 15 mol%) were 
employed, using trans-β-nitrostyrene as substrate (Table 5, entry 
1). (R)-2,2-dimethyl-4-nitro-3-phenylbutanal62 40 was obtained 
after 16 hours in 98 % yield and 90% ee using compound 30, 
while compound 31a led to comparable enantioselectivity (92% 
ee), but displayed lower activity (41% yield after 42.5 hours). 
Table 5. Catalytic enantioselective Michael reaction of 




Solvent Time [h] Yield[a] [%] ee[c,d] [%] 
1 16 (15) - 16 98 90 
2 31a (15) - 42.5 41 92 
3 16 (10) - 22 29 92 
4 16 (5) - 38 16[b] - 
5 16 (5) CH2Cl2 48 7.5[b] - 
6 16 (5) toluene 48 6.9[b] - 
7 16 (10) toluene 60 29 90 
8 16 (15) H2O 8 77 87 
[a] Isolated yields. [b] NMR conversion. [c] Determined by HPLC using a 
Chiralpak AD-H chiral stationary phase. [d] The absolute configuration of the 
products were determined by comparison of the HPLC retention times and optical 
rotations with literature values.62 
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While in the case of N-phenylmaleimide the role of the 
calixarene scaffold was to enhance the enantioselectivity (Table 
4, entries 5 vs. 6), in the case of trans-β-nitrostyrene the 
macrocycle plays a different role, being responsible of a 
consistent increase in the catalytic activity (Table 5, entries 1 vs. 
2). Further studies were devoted to decrease the catalyst loading 
to 10% and 5% (Table 5, entries 3 and 4, respectively). 
Unfortunately, activity definitely decreased, although 
enantioselectivity was still good (Table 5, entry 3). Changing 
from solvent free conditions to CH2Cl2, toluene or “on water” 
conditions (Table 5, entries 5-8) did not bring any improvement. 
The substrate scope using isobutyraldehyde with a variety of 
aromatic nitroalkenes 41-46 was then investigated under 
optimized conditions: 16 (15 mol%), solvent free (Table 6). 
Compounds 47-52 were obtained in yields ranging from 52 to 
91% and ees form 89 to 93%. Substrate substitution on the 
phenyl ring little affected the enantioselectivity, which remained 
fairly good. On the other hand, catalytic activity is highly 
substrate-dependent. Electronic effects of substituents do not 
easily justify the observed activity as the p-OMe substituted 
derivative (Table 6, entry1) afforded better yield than o-Chloro 
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and m-Bromo substituted ones (Table 6, entries 2, 4). Steric and 
solubility effects might play a role. Additionally the sterically 
demanding calixarene scaffold might prevent effective 
coordination of differently substituted nitroolefins by the 
adjacent thiourea. 
A stereochemical model for the reaction between 
isobutyraldehyde and trans-β-nitrostyrene catalyzed by 16 has 
been proposed using molecular dynamics calculations (Figure 
Table 6. Catalytic enantioselective Michael reaction of 
isobutyraldehyde with trans-β-nitroolefins. 
 
Entry R Time [h] Yield[a] [%] ee[b, c] [%] 
1 p-MeOC6H4 52 78 90 
2 o-ClC6H4 75 57 93 
3 p-FC6H4 24 91 91 
4 m-BrC6H4 51 53 90[d] 
5 Furan-2-yl 16 53 90 
6 p-BrC6H4 53 52 89 
[a] Isolated yields. [b] Determined by HPLC using a Chiralpak AD-H chiral stationary 
phase. [c] The absolute configuration of the products were determined by comparison 
of the HPLC retention times and optical rotations with literature values.62 [d] 
Determined by HPLC using a Chiralcel OD-H chiral stationary phase. 
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24). This structure, although not predicted by quantum 
mechanics methods, might represent the real transition state with 
 
Figure 24. Proposed stereochemical model for the reaction 
of isobutyraldehyde with trans-β-nitrostyrene catalyzed by 
16. 
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good approximation. In particular the reactants are at a certain 
distance from the calixarene cavity so they only interact with the 
amine-thiourea moiety during the step controlling the 
enantioselectivity, in accord with the experimental data. 
Finally, compound 16 has been tested in the catalytic 
enantioselective solvent-free addition of dimethyl malonate to 
benzylideneacetone and compared with the literature data for 
compound 31c63 (Figure 25a). A catalyst loading of 15 mol%, of 
16 in presence of benzoic acid (7.5 mol%) as a co-catalyst, 
promoted the formation of compound 53 in 88% yield and 79% 
enantiomeric excess (conditions a). On the other hand using 
 
 
Figure 25. (a) Michael reaction of dimethyl malonate with 
benzylideneacetone catalyzed by 16 and 31c. (b) Proposed 
stereochemical model. 
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compound 31c (2 mol%), combined with benzoic acid (2.5 
mol%) in toluene at 50° C resulted in comparable yield (80%) 
and slightly higher enantiomeric excess (90%). Also in this case 
the use of calixarene based catalyst 16 under solvent free 
conditions resulted in enhanced activity with respect to similar 
linear bifunctional catalysts 
Unlike addition of isobutyraldehyde to maleimides and 
nitroolefins, which are examples of enamine catalysis, Michael 
addition of malonates to enones catalyzed by primary amine-
thioureas is supposed to proceed via activation of the 
electrophile by formation of an iminium ion and simultaneous 
stabilization of the enol tautomer of the nucleophile (Figure 
25b). 
In conclusion, we reported here the synthesis of the novel 
calix[4]arene based primary amine-thiourea bifunctional 
catalyst 16. Screening of the catalytic ability of compound 16 in 
Michael type additions highlighted high efficiency and 
versatility, thus paving the way to further research directed to 
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5.1. General Overview 
 
In the last decades, more and more attention has been paid 
to reducing the production of petrochemically derived plastics, 
due to economic and environmental concerns. This situation has 
risen growing interest toward the green and degradable 
alternatives to polyolefins.64 On the cutting edge of research in 
this field are aliphatic polyesters, such as polylactide, 
polyhydroxybutyrate, polyglycolide, and polycaprolactone. 
Polylactide (PLA), obtained from lactide (LA), the cyclic dimer 
of lactic acid (produced by fermentation of glucose from corn or 
sugar beet), is a biocompatible and biodegradable polyester, its 
use has increased from the 1990s due to higher and higher 
demand for sustainable plastics, and reduction of monomer’s 
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cost. PLA has already found use as commodity polymer for 
short-time applications (e.g., packaging, fibers) and as 
engineering material in biomedical and pharmaceutical fields for 
the production of resorbable surgical sutures and stents, 
controlled drug release systems, and scaffolds for tissue 
engineering.65 
The properties of the material highly depend on the chain 
structure so macromolecules with non-linear architectures are 
getting more and more attention. Cyclic aliphatic polyesters66 
 
 
Figure 26. The lifecycle of polylactide (PLA). 
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for example display very interesting features, like the fact that 
the glass transition temperature doesn’t significantly changes 
with dimensions, or the retarded degradation profile with respect 
to linear analogues.67 Another substantial difference between 
linear and cyclic aliphatic polyesters regards the biological 
properties. Not only does cyclic topology increase the blood 
circulation time68 and tumor uptake,69 but it also might lead to 
enhanced supramolecular properties. The sum of these qualities 
makes cyclic aliphatic polyesters suitable scaffolds for 
biomedical applications. Unfortunately this very interesting 
 
Figure 27. Solid phase synthesis of cyclic PLA 
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class of polymers have received little attention because of the 
difficulties in both preparation and purification.70 A possible 
synthetic strategy consists in growing a polyester chain on a 
solid support, than the statistical intramolecular 
transesterification releases cyclic polymers in solution.71 (Figure 
27). Another approach is the cyclization using high dilution 
conditions of α,ω-functionalized linear chains. A final important 
technique is the so called ring expansion polymerization. The 
main feature of this approach is the absence of linear polyesters 
as intermediate, since the macromolecules are generated by 
addition of monomers into a labile bond of a cyclic initiator. The 
bond can be either a metal oxygen bond (generally Sn-O) of an 
organometallic complex,72 or the connection between an 
alkoxide and an imidazolium ion pair generated by the addition 
of N-heterocyclic carbenes to a monomer unit.73 Waymouth et 
al. reported an example of such a strategy in the synthesis of 
PLA. The first step is the nucleophile attack of 1,3-
dimesitylimidazol-2-ylidene to a LA molecule, thus generating 
the cyclic zwitterionic initiator. The alkoxide moiety then 
attacks other LA units in the propagation step. Finally, the 
backbiting transesterification releases the cyclic PLA (Figure 
28). 
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At the best of our knowledge, synthesis of cyclic polyesters 
using the well-established procedure, consisting in the ring-
opening polymerization (ROP) of LA catalyzed by metal 
complexes,74 has not been so far reported. In order to develop a 
catalytic ROP system able to selectively yield cyclic polymers a 
fine tuning of both metal and ligand is needed. 
For example one of the most relevant metal complexes, 
especially from an industrial point of view, is Sn(Oct)2, which is 
toxic, hence tin employment in biomedical applications should 
be avoided, preferring biocompatible metals like zinc or 
titanium. 
 
Figure 28. Zwitterionic N-heterocyclic carbene catalyzed 
ring expansion cyclopolymerization of lactide. 
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Recently bimetallic complexes are gaining more attention as 
a promising class of catalysts.75 Tolman and coworkers 
showed76 that a binuclear zinc metal alkoxide was a highly 
active catalyst for the preparation of PLA. In addition, a study 
by Williams and coworkers, comparing the performances of di- 
and monozinc catalysts, showed that synergistic effect between 
two metal centers enhances the activity of binuclear catalysts 
with respect to mononuclear analogues. 
Group 4 metal complexes have been widely studied in the 
ROP of cyclic esters because of their low toxicity and good 
control over polymerization process.77 Surprisingly, at the best 
of our knowledge, only few dinuclear group 4 catalysts have 
found use in the ROP of LA.78 
Beyond the choice of the metal, the other issue in order to 
lead the polymerization process to the formation of cyclic 
polyesters, is the choice of a suitable rigid, bulky ligand. 
Calix[n]arenes, being composed of phenol units connected by 
methylene bridges, constitute an ideal platform for the synthesis 
of metal complexes: the calixarene moiety behaves as an oxo 
surface protecting one side of the complex, thus conferring 
significant stability. Some titanium complexes bearing tiny, 
rigid, preorganized calix[4]arenes have already been reported 
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and used in the polymerization of cyclic esters.79 However, 
larger, flexible and less preorganized calixarenes are the ideal 
framework for designing bimetallic catalysts, because they are 
able to coordinate more than one metal simultaneously in close 
proximity, as in the titanium p-tert-butylcalix[8]arene complex 
[Ti4(p-tert-butylcalix[8]arene)(O
nPr)8(THF)2] reported by 
McIntosh and coworkers.80 This complex has two main features. 
One is the conformation adopted by the calixarene ligand, 
usually referred to as double cone, because it resembles two 
reversed calix[4]arene in the cone conformation. The other is 
that each calix[4]arene-like unit coordinates two titanium 
centers connected by two bridging propoxides. The complex 
Catalyzed the ROP of LA, even though no data have been 
reported (Figure 29.) 
 
Figure 29. (a) Complex Ti4(p-tert-butylcalix[8]arene) 
(OnPr)8(THF)2. (b) The orthogonal view. 
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Unlike calix[4]arene scaffold, which undergoes little 
changing during coordination to metal centers, calix[8]arene 
flexibility allows substantial structure modification with the 
ligand adapting its shape to the metals, thus obtaining peculiar 
architectures with interesting properties. On the other hand, too 
much flexibility could result in many possible conformers, thus 
complicating the study of such systems. 
In fact in the anionic [Ti2(p-tert-butylcalix[8]arene)(O
iPr)2]-
species, the calix[8]arene ligand adopts a so called ‘tennis-ball’ 
conformation, with four phenolic oxygens coordinated to each 
Ti(IV),81 different from the double cone described previously. 
Working with Prof. A. Grassi, Dr. S. Milione, Dr. A. 
Buonerba, and Dr. R. Lapenta, complex 17(Zr-O-tBu)2 has been 
prepared, featuring a calix[8]arene ligand bridged between the 
first and fifth phenolic group with a m-xylene-diyl functionality. 
The choice was made in order to reduce the number of 
conformers the ligand can adopt, thus balancing flexibility and 
preorganization. Moreover, we focused on zirconium complexes 
because of their higher activity with respect to titanium 
analogues.77 Using such a ligand has also the purpose of locating 
the metal atoms in an open catalytic pocket thus creating an 
enzyme-like environment conferring to complex 17(Zr-O-tBu)2 
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peculiar properties in the ring opening polymerization of rac-
lactide (LA), ε-caprolactone (ε-CL) and β-butyrolactone (β-BL). 
 
5.2. Synthesis of the Dinuclear Zirconium Complex Bearing 
1,5-Bridged-Calix[8]arene Ligand  
 
The calix[8]arene, 1,5-bridged with a m-xylene-diyl 
functionality 17H6 (Figure 32) was synthesized according to the 
procedure reported in literature.82 The protonolysis of 17H6 with 
two equivalents of Zirconium(IV) tert-butoxide, in toluene (or 
THF) at room temperature, yielded complex 17(Zr-O-tBu)2 
 
Figure 30. Synthesis of 17(Zr-O-tBu)2. 
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(Figure 30), which was recovered after crystallization in toluene. 
Unfortunately, the needle-shaped crystals obtained were 
unsuitable for single x-ray diffraction, so structure elucidation 
of complex 17(Zr-O-tBu)2 was made combining mono- (
1H, 13C 
NMR, DEPT135) and two-dimensional (2D COSY, 2D HSQC, 
2D NOESY) NMR techniques with high resolution mass 
spectrometry (see experimental section). 
As expected 1H NMR spectra of ligand 17H6 recorded at 25 
°C features only sharp singlets (Figure 32), suggesting fast 
rotation of the phenol units around the methylene bridges. On 
the other hand, the 1H NMR spectra of 17(Zr-O-tBu)2 acquired 
in a polar coordinating solvent (pyridine-d5) showed sharp 
signals even at high temperature (Figure 31). Noteworthy, the 
methylene protons on the calixarene ring resonate as two AX 
spin systems (δ = 3.22 and 4.82 ppm with J of 14.5 Hz; δ = 3.03 
and 4.30 ppm with J of 12.4 Hz), clearly indicating a blocked 
conformation, on the NMR time scale. Moreover, a singlet 
signal was found for the methylenes of the di-ether bridge of the 
macrocycle (5.12 ppm, Figure 31), suggesting that the calix 
bridge is crossed by a plane of symmetry. The presence of two, 
instead of three AX systems can be explained by the presence of 
a further plane of symmetry perpendicular to that containing the 
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bridge, through which passes a C2 axis; whole indicating a C2v 
symmetry for the complex. This conclusion is confirmed by the 
presence of four types of aromatic protons. The integration ratio 
between the signals due to the tert-butoxide groups bounded to 
the zirconium atoms and the tert-butyl on the calixarene 
macrocycle is coherent with the presence of two tert-butoxide 




Figure 31. 1H NMR spectra, with the diagnostic signals labelled, of complex 17(Zr-O-tBu)2 




Figure 32. 1H NMR spectra, with the diagnostic signals labelled, of ligand 17H6 (600 MHz, 
CDCl3, 25°C). 
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The structure proposed for 17(Zr-O-tBu)2 after NMR 
investigation, was optimized by DFT calculations and depicted 
in Figure 33.  
In this structure, the calixarene adopts a double-cone 
conformation with the two calix[4]arene subunits in a “syn-
cones” orientation. Each substructure bounds a Zirconium atom. 
The ligand is folded in such a way to direct the two substructures 
toward one another locating the two-Zirconium atoms in close 
proximity and enabling the formation of a four-membered 
alkoxo-bridged Zr–O–Zr–O ring. The bridging and terminal 
alkoxo groups bind to the Zirconium atoms with typical bond 
 
Figure 33. (a) Minimum-energy structure for 17(Zr-O-tBu)2. 
(b) Top and (c) front views of the minimum-energy structure 





lengths of 2.18–2.27 and 1.98–2.01 Å, respectively. In this 
structure, each Zirconium atom is in a pentacoordinated 
environment, the saturation of the coordination sphere can occur 
with the binding of a pyridine molecule for each metal center. 
DFT calculation on a model complex (the complex lacking of 
tert-butyl groups) predicted the coordination of two pyridines to 
be exothermic by 17.9 kcal/mol. That assumption has been 
confirmed by NMR analysis of the complex synthesized in 
toluene and in solution treated with pyridine. 
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5.3. Ring Opening Polimerization of rac-LA, ε-CL and β-BL  
 
Complex 17(Zr-O-tBu)2 has been tested in the ROP of LA. 
Initially, activity screening was performed varying temperature 
at monomer/catalyst ratio of 100 (Table 7, entries 1-4). 
Increasing temperature resulted in increasing activity, given that 
97% conversion is reached in 30 minutes at 100 °C and a 
turnover frequency of 194 h-1 (Table 7, entry 4). Polymers 
obtained had all narrow molecular weight distributions (PDI = 
1.10-1.30), anyway measured molecular weights were far lower 
than the calculated ones, thus indicating transesterification 
reactions occurring during the ROP.
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1 g) rac-LA 100 25 1440 50 50 2 629 3603 1.10 
2 rac-LA 100 50 660 90 90 8 686 6486 1.14 
3 rac-LA 100 80 108 93 93 52 629 6702 1.28 
4 rac-LA 100 100 30 97 97 194 705 6990 1.23 
a) Reaction conditions: Complex 17(Zr-O-tBu)2 (4.6 μmol, 7.8 mg) and toluene (2.4 mL). b) Determined by 1H NMR 
spectroscopy (CDCl3 as solvent, 25 °C). c) Turnover number (mol of polymerized rac-Lactide per mol of catalyst). d) Turnover 
frequency (TON per reaction time). e) Experimental molecular weight (Mn(exp)) and polydispersity index (PDI, Mw/Mn) 
determined by GPC in THF using polystyrene standards and corrected using a factor of 0.58. f) Calculated molecular weight 
using: Mn(th) (kg mol−1) = 144.13×[([rac-LA]0/[C])/2]×(rac-LA conversion). g) Dichloromethane as solvent. 
92 
 


















1 rac-LA 250 100 40 93 233 349 3209 16755 1.28 
2 rac-LA 500 100 60 96 480 480 8579 34591 1.27 
3 rac-LA 750 100 80 98 735 551 15760 52968 1.30 
4 rac-LA 1000 100 100 98 980 588 26619 70624 1.47 
5 ε-CL 100 100 3 97 97 3233 621 5536 1.23 
6 β-BL 100 100 840 90 90 6.4 599 3874 1.25 
a) Reaction conditions: Complex 17(Zr-O-tBu)2 (4.6 μmol, 7.8 mg) and toluene (2.4 mL). b) Determined by 1H NMR spectroscopy 
(CDCl3 as solvent, 25 °C). c) Turnover number (mol of polymerized rac-Lactide per mol of catalyst). d) Turnover frequency (TON 
per reaction time). e) Experimental molecular weight (Mn(exp)) and polydispersity index (PDI, Mw/Mn) determined by GPC in THF 






Figure 34. MALDI-TOF-MS spectra (on the left), the corresponding molecular weight 
distribution profiles with assignments for the cyclic and the linear polymer chains (in the 
middle) and the cyclic/linear molar ratio for the polymer chains as a function of the number of 




Figure 35. Proposed mechanism for the intramolecular 
transesterification reaction. 
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In order to highlight the phenomenon, matrix assisted laser 
desorption ionization time of flight mass spectrometry (MALDI-
TOF-MS) analysis of the polymer were performed (Figure 34). 
The mass spectrum for PLA (Figure 34a) shows signals 
undoubtedly ascribable to cyclic polyesters adduct with Na+ and 
K+, thus confirming that intramolecular transesterification 
reaction occur during polymerization. Linear PLA chains 
including tert-butyl moiety were also found as minority 
products. Cyclic/linear PLA ratio reaches maximum level at 
three different values of monomer units, thus suggesting that 
only certain conformations of the growing chain favor the 
cyclization reaction. The process probably occurs when the 
growing chain fold in order to bring one of the carbonyl groups 
in close proximity to the metal center. Non-covalent interactions 
between the growing chain and the two zirconium atoms activate 
the carbonyl facilitating the cyclization reaction (Figure 35). 
Following screening of the catalytic activity was made 
increasing the monomer/catalyst ratio in order to determine the 
relevance of the transesterification reaction with respect to the 
monomer coordination/insertion (Table 8, entries 1-4). 
Surprisingly 17(Zr-O-tBu)2 is still active even at high monomer 
loading, as quantitative conversion of 1000 equiv. of LA at 100 
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°C required 100 minutes (Table 8, entry 4). As the 
monomer/catalyst ratio increased, molecular weights also 
increased. Even the difference between measured and calculated 
molecular weights increased, thus highlighting that high 
monomer concentrations favor the transesterification reaction 
with respect to the propagation. 
Complex 17(Zr-O-tBu)2 was also screened in the 
polymerization of ε-CL and β-BL (Table 8, entries 5 and 6). 
Conversion of ε-CL was total after 3 minutes, while β-BL 
required 14 hours to afford the corresponding polymer P3HB in 
high yield. As PLA, molecular weights were narrowly 
distributed, although measured values were lower than 
calculated ones. Also in this case, transesterification reaction 
prevails over propagation. MALDI-TOF-MS analysis of the 
polymers (Figure 34b and c) highlighted the formation of cyclic 
oligomers as main product. Analysis of cyclic/linear polymer 
ratio in function of the number of monomer units reveals the 
absence of specific chain lengths favoring the cyclization 
reaction, as a result of higher flexibility of PCL and P3HB with 
respect to PLA, in particular the maximum ratio for PCL reaches 
up to ten monomer units of ε-CL. 
97 
In conclusion, the protonolysis of ligand 17H6 with Zr(IV) 
tert-butoxide afforded complex 17(Zr-O-tBu)2, whose structure, 
determined by NMR analysis, showed C2v symmetry. Complex 
17(Zr-O-tBu)2 proved to be an active catalyst in the ring opening 
polymerization of LA, ε-CL and β-BL, thus promoting a general 
method for the synthesis of cyclic polyesters. Since synthesis 
and purification of such compounds generally is a hard task, we 
hope that our work could help developing new easy strategies 






















6.1 General Information.  
 
HR MALDI mass spectra were acquired on a FT-ICR mass 
spectrometer equipped with a 7T magnet. All chemicals were 
reagent grade and were used without further purification. 
Compounds 2483 and 2584 were prepared as reported in the 
literature. Anhydrous solvents were used as purchased from the 
supplier. When necessary compounds were dried in vacuo over 
CaCl2.or P2O5 Reaction temperatures were measured externally. 
Reactions were monitored by TLC silica gel plates (0.25 mm) 
and visualized by UV light, or by spraying with H2SO4-
Ce(SO4)2, ninhydrin or anisaldeide. Flash chromatography was 
performed on silica gel 60 (particle size: 0.040−0.063 mm) and 
the solvents employed were of analytical grade. Enantiomeric 
excesses of products 23a-e 39, 40, 47-52were determined by 
chiral HPLC using Chiralcel or Daicel columns with an UV 
detector set at 260 nm. Optical rotation values were measured at 
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λ = 589 nm, corresponding to the sodium D line, at the 
temperatures indicated. NMR spectra were recorded on a 600 
[600 (1H) and 150 MHz (13C)], 400 MHz spectrometer [400 (1H) 
and 100 MHz (13C)] or 300 MHz spectrometer [300 (1H) and 75 
MHz (13C)]. Chemical shifts are reported relative to the residual 
solvent peak (CHCl3: δ 7.26, CDCl3: δ 77.23; TCDE: δ 6.0, 
TCDE: δ 74.0). Standard pulse programs, provided by the 
manufacturer, were used for 2D COSY and 2D HSQC 
experiments. One-dimensional 1H and 13C spectra, and two-
dimensional COSY-45 and heteronuclear single quantum 
correlation (HSQC) were used for NMR peak assignment. 
COSY-45 spectra were taken using a relaxation delay of 2 s with 
30 scans and 170 increments of 2048 points each. HSQC spectra 
were performed with gradient selection, sensitivity 
enhancement, and phase-sensitive mode using Echo/Antiecho-
TPPI procedure. A typical experiment comprised 20 scans with 
113 increments of 2048 points each. Glassware and vials used in 
the polymerization were dried in an oven at 120 °C overnight 
and exposed three times to vacuum−nitrogen cycles. All 
solvents and reagents used were dried and purified before use. 
Toluene (Sigma-Aldrich, 99.5%) and hexane (Sigma-Aldrich, 
99%) were preliminarily dried over Calcium chloride, while 
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THF (Sigma-Aldrich, 99%) was preliminarily treated with 
potassium hydroxide. Then, all solvents were purified by 
distillation from sodium under a nitrogen atmosphere.
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6.2. Synthesis of Catalysts 
 
6.2.1. Synthesis of Derivative 11. 
 Oxalyl chloride (0.88 mL, 10 mmol) was slowly added to a 
stirred solution of 1737 (0.22 g, 0.27 mmol) in 10 mL of dry 
CHCl3 at 0 °C. The reaction mixture was refluxed under nitrogen 
atmosphere for 15 h, then was cooled at room temperature and 
the solvent was removed under reduced pressure to give a dark 
solid. The crude product was dissolved in 5 mL of dry CHCl3 
and added dropwise to a stirred solution of (S)-α-
methylbenzylamine (0.10 mL, 0.80 mmol) and dry Et3N (0.11 
mL, 0.80 mmol) in 10 mL of dry CHCl3 at 0 °C. The reaction 
mixture was stirred for 15 h at room temperature under nitrogen 
atmosphere, then was washed with a 1N aqueous solution of HCl  
(2 × 5 mL). The aqueous phase was extracted with CHCl3 (3 × 
5 mL). The collected organic layers were washed with H2O (10 
mL), dried over Na2SO4 and evaporated under reduced pressure. 
The crude product was purified by column chromatography 
(SiO2, CHCl3) to give the compound 11 as a white solid (0.060 
g, 20 % yield): mp 126−128 °C; [α]D
20 = −38.5±0.7 (c = 0.100, 
CHCl3); 1H NMR (400 MHz, CDCl3, 298 K): δ 8.06 (d, J = 8.2 
Hz, NH, 1H), 7.48 – 7.07 (overlapped ArH + NH, 21H), 6.79 (d, 
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J = 8.2 Hz, NH, 1H), 6.52 (s, ArH, 1H), 6.51 (s, ArH, 1H), 6.48 
(s, ArH, 1H), 6.44 (s, ArH, 1H), 5.31 – 5.28 (overlapped, 
CHPhCH3 + OH, 3H), 5.09 (m, CHPhCH3, 1H), 4.66 (d, J = 14.6 
Hz, OCH2CO, 1H), 4.37 (d, J = 13.8 Hz, OCH2CO, 1H), 4.29 
(d, J = 13.3 Hz, ArCH2Ar, 1H), 4.23 (d, J = 14.6 Hz, OCH2CO, 
1H), 4.19 (d, J = 13.1 Hz, ArCH2Ar, 1H), 4.14 (d, J = 13.8 Hz, 
OCH2CO, 1H), 4.07 (d, J = 12.9 Hz, ArCH2Ar, 1H), 3.75 (d, J 
= 13.1 Hz, ArCH2Ar, 1H), 3.50 (d, J = 13.7 Hz, OCH2CO, 1H), 
3.38 (d, J = 13.3 Hz, ArCH2Ar, 1H), 3.17 (d, J = 13.1 Hz, 
ArCH2Ar, 2H), 3.12 (d, J = 13.7 Hz,, OCH2CO, 1H) 3.03, (d, J 
= 12.9 Hz, ArCH2Ar, 1H), 1.74 (d, J = 7.0 Hz, CHPhCH3, 3H), 
1.67 (d, J = 7.0 Hz, CHPhCH3, 3H), 1.58 (d, J = 6.9 Hz, 
CHPhCH3, 3H), 1.37 (s, C(CH3)3, 9H), 1.36 (s, C(CH3)3, 9H), 
0.83 (s, C(CH3)3, 9H), 0.77 (s, C(CH3)3, 9H). 13C NMR (100 
MHz, CDCl3, 298 K): δ 168.9, 167.9, 167.5, 151.9, 151.6, 151.5, 
149.8, 147.6, 146.7, 146.5, 143.3, 143.0, 142.8, 142.7, 135.4, 
135.2, 131.6, 131.1, 130.8, 130.4, 128.9, 128.8, 128.7, 128.4, 
128.3, 128.0, 127.8, 127.6, 126.9, 126.7, 126.6, 125.8, 125.7, 
125.5, 125.5, 125.3, 75.8, 75.7, 74.0, 49.5, 49.0, 48.9, 34.4, 34.2, 
33.9, 33.8, 32.1, 31.9, 31.8, 31.5, 31.3, 31.1, 21.9, 21.3, 20.1. 






















Figure 39. 2D COSY-45 spectrum (400 MHz, CDCl3, 
298 K) of 11. 
 
Figure 40. Section of 2D COSY-45 




6.2.2. Synthesis of Derivative 12. 
Oxalyl chloride (1.5 mL, 18 mmol) was slowly added to a 
stirred solution of 19 (0.38 g, 0.46 mmol) in 20 mL of dry CHCl3 
at 0 °C. The reaction mixture was refluxed under nitrogen 
atmosphere for 13 h, then was cooled at room temperature and 
the solvent was removed under reduced pressure to give a dark 
solid. The crude product was dissolved in 13 mL of dry CHCl3 
and added dropwise to a stirred solution of (S)-α-
methylbenzylamine (0.18 mL, 1.4 mmol) and dry Et3N (0.19 
mL, 1.4 mmol) in 23 mL of dry CHCl3 at 0 °C. The reaction 
mixture was stirred for 22 h at room temperature under nitrogen 
atmosphere, then was washed with a 1N aqueous solution  of 
HCl  (2 × 15 mL). The aqueous phase was extracted with CHCl3 
(3 × 10 mL). The collected organic layers were washed with H2O 
(20 mL), dried over Na2SO4 and evaporated. The crude product 
was purified by column chromatography (SiO2, CHCl3/hexane 
from 6/4 to 9/1 (v/v)) to give the derivative 12 as a white solid 
(0.22 g, 57 %): mp 140 −143 °C; [α]D
20 = − 26.4 ± 0.4 (c = 1.00, 
CHCl3); 1H NMR (400 MHz, CDCl3, 298 K): δ 7.73 (broad, NH, 
1H), 7.70 (d, J = 8.4 Hz, NH, 1H), 7.46 (d, J = 7.2 Hz, ArH, 2H), 
7.40 (d, J, = 7.2 Hz, ArH, 2H), 7.28 – 7.02 (overlapped, ArH, 
15H), 6.78 (broad, NH, 1H), 6.47 – 6.45 (overlapped, ArH, 3H), 
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6 40 (s, ArH, 1H), 5.35 – 5.27 (m, NCHPhCH3, 2H), 5.04 – 5.00 
(m, NCHPhCH3, 1H), 4.69 – 4.60 (overlapped, OCH2CO, 2H), 
4.49 (d, J = 13.2 Hz, ArCH2Ar, 1H), 4.30 (d, J = 13.2 Hz, 
ArCH2Ar, 1H), 4.22 (s, OCH2CO, 2H), 4.13 (s, OCH2CO, 2H), 
4.11 (d, J = 12.4 Hz, ArCH2Ar, 1H), 4.08 (d, J = 12.4 Hz, 
ArCH2Ar, 1H), 3.74 (s, OCH3, 3H), 3.24 (overlapped, ArCH2Ar, 
3H), 2.94 (d, J = 13.2 Hz, ArCH2Ar, 1H), 1.65 (d, J = 6.8 Hz, 
CHPhCH3, 3H), 1.58 (d, J = 7.2 Hz, CHPhCH3, 3H), 1.41 (d, J 
= 6.8 Hz, CHPhCH3, 3H), 1.34 (s, C(CH3)3, 9H), 1.33 (s, 
C(CH3)3, 9H), 0.86 (s, C(CH3)3, 9H), 0.85 (s, C(CH3)3, 9H). 13C 
NMR (100 MHz, CDCl3, 298 K): δ 168.33, 168.28, 168.1, 
154.9, 153.1, 152.0, 145.8, 145.6, 145.2, 145.1, 143.3, 143.1, 
142.8, 134.9, 134.7, 134.7, 131.3, 131.3, 130.8, 128.5, 128.4, 
127.2, 126.5, 126.3, 126.2, 126.1, 125.8, 125.1, 124.7, 124.6, 
74.7, 74.6, 60.2, 48.7, 48.5, 48.3, 34.1, 33.6, 31.6, 31.5, 31.2, 
31.0, 21.8, 21.5, 21.2. HRMS (ESI+) m/z [M + Na]+ calcd for 




















Figure 44. 2D COSY-45 spectrum (400 MHz, CDCl3, 
298 K) of 12. 
 
 
Figure 45. Section of  2D COSY-45 











Figure 47. Section of HSQC spectrum 
(400 MHz, CDCl3, 298 K) of 12. 
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6.2.3. Synthesis of Derivative 13. 
Oxalyl chloride (0.27 mL, 3.2 mmol) was slowly added to a 
stirred solution of 20 (0.097 g, 0.12 mmol) in 5 mL of dry CHCl3 
at 0 °C. The raction mixture was refluxed under nitrogen 
atmosphere for 16 h, then was cooled at room temperature and 
the solvent removed under reduced pressure to give a white 
solid. The crude product was dissolved in 1 mL of dry CHCl3 
and added dropwise to a stirred solution of (S)-α-
methylbenzylamine (0.03 mL, 0.2 mmol) and dry Et3N (0.03 
mL, 0.2 mmol) in 3 mL of dry CHCl3 at 0 °C. The reaction 
mixture was stirred for 64 h at room temperature under nitrogen 
atmosphere, then was washed with a 1N aqueous solution of HCl 
(2 × 5 mL). The aqueous phase was extracted with CHCl3 (3 × 
5 mL). The collected organic layers were washed with H2O (5 
mL), dried over Na2SO4 and evaporated. The crude product was 
purified by column chromatography (SiO2, CHCl3) to afford 13 
as a white solid (0.096 g, 80 % ): mp 237-239 °C; [α]D
20 = 
−34.68 ± 0.04 (c = 0.997, CHCl3); 1H NMR (600 MHz, CDCl3, 
298 K): δ 7.30 – 7.20 (overlapped, NH + ArH, 12H), 7.12 (s, 
ArH, 4H), 6.42 (s, ArH, 4H), 5.31 (overlapped, COCHPhCH3, 
2H), 4.27-4.21 (overlapped, OCH2CO, 4H), 4.11 (broad, 
ArCH2Ar, 4H), 3.69 (s, OCH3, 6H), 3.20 (broad, ArCH2Ar, 4H), 
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1.49 (d, J = 6.6 Hz, CHPhCH3, 6H), 1.32 (s, C(CH3)3, 18H), 0.81 
(s, C(CH3)3, 18H). 13C NMR (150 MHz, CDCl3, 298 K): δ 
168.4, 154.8, 146.3, 145.5, 142.6, 135.3, 131.1, 131.0, 128.9, 
127.7, 126.1, 125.0, 74.3, 60.3, 48.0, 34.3, 33.7, 31.8, 31.1, 21.7. 





































Figure 54. Section of HSQC 





6.2.4. Synthesis of Derivative 14. 
Oxalyl chloride (0.26 mL, 3.1 mmol) was slowly added to a 
stirred solution of 21 (0.18 g, 0.24 mmol) in 10 mL of dry CHCl3 
at 0 °C. The reaction mixture was refluxed under nitrogen 
atmosphere for 19 h, then was cooled at room temperature and 
the solvent was removed under reduced pressure to give a white 
solid. The crude product was dissolved in 6 mL of dry CHCl3 
and added dropwise to a stirred solution of (S)-α-
methylbenzylamine (0.03 mL, 0.2 mmol) and Et3N (0.03 mL, 
0.2 mmol) in 3 mL of dry CHCl3 at 0 °C. The reaction mixture 
was stirred for 16 h at room temperature under nitrogen 
atmosphere, then was washed with a 1N aqueous solution of HCl 
(2 × 5 mL). The aqueous phase was extracted with CHCl3 (3 × 
5 mL). The collected organic layers were washed with H2O (10 
mL), dried over Na2SO4 and evaporated. The crude product was 
purified by column chromatography (SiO2, CH2Cl2) to afford 14 
as a white solid (0.12 g, 60 %): mp 106 −107 °C; [α]D
20 = − 15.4 
± 0.8 (c = 1.00, CHCl3); 1H NMR (600 MHz, TCDE, 353 K): δ 
7.22 (s, ArH, 5H), 7.13 (s, NH, 1H), 6.94 – 6.87 (overlapped, 
ArH, 4H), 6.65 (s, ArH, 2H), 6.51 (s, ArH, 2H), 5.16 (broad, 
COCHPhCH3, 1H), 4.15 (broad, OCH2CO, 2H), 4.00 (broad, 
ArCH2Ar, 2H), 3.88 (broad, ArCH2Ar, 4H), 3.33 (s, OCH3, 3H), 
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3.20 (s, OCH3, 6H), 3.14 (broad, ArCH2Ar, 2H), 1.45 (broad, 
CHPhCH3, 3H), 1.17 (s, C(CH3)3 9H), 1.14 (s, C(CH3)3, 9H), 
0.98 (s, C(CH3)3, 9H), 0.83 (s, C(CH3)3, 9H). 13C NMR (150 
MHz, TCDE, 353 K): δ 168.5, 155.1, 154.8, 152.0, 145.3, 144.3, 
143.0, 134.6, 134.3, 132.7, 131.7, 128.7, 127.4, 126.2, 126.1, 
125.5, 125.4, 125.3, 74.2, 60.4, 60.1, 49.6, 48.3, 34.0, 34.0, 33.7, 
33.7, 31.7, 31.6, 31.4, 31.2, 29.7, 21.3. HRMS (ESI+) m/z [M + 




















Figure 58. 2D COSY-45 spectrum (600 MHz, TCDE, 353 
K) of 14. 
 
 
Figure 59. Section of 2D COSY-45 
spectrum (600 MHz, TCDE, 353 K) of 
14. 
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6.2.5. Synthesis of Derivative 15. 
Oxalyl chloride (0.78 mL, 9.3 mmol) was slowly added to a 
stirred solution of 19 (0.20 g, 0.24 mmol) in 10 mL of dry CHCl3 
at 0 °C. The reaction mixture was refluxed under nitrogen 
atmosphere for 15 h, then was cooled at room temperature and 
the solvent was removed under reduced pressure to give a white 
solid. The crude product was dissolved in 7 mL of dry CHCl3 
and added dropwise to a stirred solution of (S)-1-(2-
naphthyl)ethylamine  (0.22 g, 1.3 mmol) and dry Et3N (0.18 mL, 
1.3 mmol) in 13 mL of dry CHCl3 at 0 °C. The reaction mixture 
was stirred for 63 h at room temperature under nitrogen 
atmosphere, then was washed a 1N aqueous solution of HCl (2 
× 10 mL).  The aqueous  phase was extracted with CHCl3 (3 × 
10 mL). The collected organic layers were washed with H2O (25 
mL), dried over Na2SO4 and evaporated. The crude product was 
purified by column chromatography (SiO2, CH2Cl2/Et2O 96/4 
(v/v)) to afford compound 15 as white solid (0.24 g, 76 %): mp 
138-139 °C; [α]D
20 = − 424 ± 4 (c = 0.0938, CHCl3); 1H NMR 
(600 MHz, CDCl3, 298 K): δ 7.88 (s, ArH, 1H), 7.85 (broad, 
NH, 1H), 7.83 (broad, NH, 1H), 7.81 (s, ArH, 1H), 7.75 – 7.63 
(overlapped, ArH, 7H), 7.58 (s, ArH, 1H), 7.57 (s, ArH, 1H), 
7.51 (s, ArH, 1H), 7.50 (s, ArH, 1H), 7.47 (broad, NH, 1H), 7.55 
132 
– 7.37 (overlapped, ArH, 6H), 7.13 (d, J = 1.8 Hz, ArH, 1H), 
7.12 (d, J = 1.8 Hz, ArH, 1H), 7.09 (s, ArH, 2H), 7.06 (d, J = 2.4 
Hz, ArH, 1H), 6.94 (d, J = 2.4 Hz, ArH, 1H), 6.50 (broad, ArH, 
1H), 6.47 (broad, ArH, 1H), 6.45 (d, J = 2.4 Hz, ArH, 1H), 6.36 
(d, J = 1.8 Hz, ArH, 1H), 5.49 – 5.43 (overlapped, COCHPhCH3, 
2H), 5.11 – 5.08 (m, COCHPhCH3, 1H), 4.75-4.71 (overlapped, 
OCH2CO, 2H), 4.53 (d, J = 13.2 Hz, ArCH2Ar, 1H), 4.34 (d, J 
= 12.6 Hz, ArCH2Ar, 1H), 4.25 (broad, OCH2CO, 2H), 4.17 – 
4.12 (overlapped, OCH2CO, 2H), 4.10 – 4.06 (overlapped, 
ArCH2Ar, 2H), 3.73 (s, OCH3, 3H), 3.23 – 3.21 (overlapped, 
ArCH2Ar, 2H), 3.17 (d, J = 13.2 Hz, ArCH2Ar, 1H), 2.87 (d, J 
= 12.6 Hz, ArCH2Ar, 1H), 1.74 (d, J = 7.2 Hz, CHPhCH3, 3H), 
1.60 (d, J = 7.2 Hz, CHPhCH3, 3H), 1.39 (d, J = 6.6 Hz, 
CHPhCH3, 3H), 1.31 (s, CCH3, 9H), 1.30 (s, CCH3, 9H), 0.87 
(s, CCH3, 9H), 0.84 (s, CCH3, 9H). 13C NMR (150 MHz, CDCl3, 
298 K): δ 168.6, 155.1, 152.3, 145.4, 145.2, 140.9, 140.6, 140.3, 
134.8, 134.6, 133.4, 133.3, 132.8, 132.7, 131.5, 131.1, 128.5, 
128.4, 128.3, 128.1, 128.0, 128.0, 127.7, 127.7, 126.2, 126.1, 
126.0, 125.9, 125.8, 125.4, 125.2, 125.0, 124.9, 124.8, 74.8, 
60.4, 48.8, 48.6, 34.2, 34.2, 33.8, 33.7, 31.7, 31.2, 21.8, 21.4, 






















Figure 63. 2D COSY-45 spectrum (400 MHz, CDCl3, 




Figure 64. Section of the 2D COSY-45 









Figure 66. Section of  the HSQC 




6.2.6. Synthesis of Derivative 18. 
CH3I (0.38 mL, 6.09 mmol) was added to a suspension of 
16 (0.55 g, 0.61 mmol) and K2CO3 (0.34 g, 2.44 mmol) in 
CH3CN (15 mL) at 0 °C. The reaction mixture was refluxed for 
15 h. The solvent was evaporated under reduced pressure and 
the crude product was suspended in CH2Cl2 (30 mL) and washed 
with a 1N aqueous solution of HCl (2 × 15 mL). The aqueous 
layer was extracted with CH2Cl2 (3 × 10 mL). The collected 
organic layers were washed with H2O, dried over Na2SO4 and 
evaporated. The crude product was triturated with methanol, 
filtered and the solid was washed with cold methanol to give the 
derivative 18 as a white solid (0.39 g, 70 % yield): mp >250 °C 
dec; 1H NMR (600 MHz, TCDE, 353 K): δ 6.96 (s, ArH, 2H), 
6.88 (s, ArH, 2H), 6.64 (broad, ArH, 1H), 6.48 (broad, ArH, 1H), 
6.43 (s, ArH, 2H), 4.64 – 4.62 (overlapped, OCH2 + ArCH2Ar, 
4H), 4.54 (d, J = 12.6 Hz, ArCH2Ar, 2H), 4.37 (s, OCH2CO, 
2H), 4.29 (s, OCH2CO, 2H), 4.12 (q, J = 7.2 Hz, OCH2CH3, 4H), 
4.00 (q, J = 7.2 Hz, OCH2CH3, 2H), 3.65 (s, OCH3, 3H), 3.05 
(d, J = 12.6 Hz, ArCH2Ar, 4H), 1.18 – 1.16 (overlapped, 
C(CH3)3, + OCH2CH3, 24H), 1.09 (t, J = 6.6 Hz, OCH2CH3, 3H), 
0.81 (s, C(CH3)3, 18H). 13C NMR (150 MHz, TCDE, 353 K): δ 
171.0, 169.7, 156.2, 156.1, 153.4, 145.5, 145.2, 135.1, 133.7, 
139 
132.5, 132.1, 132.0, 126.0, 125.7, 125.5, 125.3, 74.5, 72.3, 71.8, 
60.7, 60.2, 51.5, 34.2, 34.1, 33.8, 32.4, 31.8, 31.6, 31.5, 14.4, 
14.3, 14.3. (ESI+) m/z [M+Na]+: 943.5 Anal. Calcd for 















Figure 69. ESI (+) MS spectrum of derivative 18. 
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6.2.7. Synthesis of Derivative 19. 
A suspension of NaOH (0.57 g, 14 mmol) in EtOH (4 mL) 
and H2O (3 mL) was added to a solution of 18 (0.44 g, 0.47 
mmol) in EtOH (14 mL). The reaction mixture was refluxed for 
14 h. Then the solvent was evaporated under reduced pressure 
and the crude product was triturated with a 1N aqueous solution 
of HCl, filtered and the solid washed with cold H2O and dried in 
vacuo to give the derivative 19 as a white solid (0.38 g, 96 %): 
mp 248 −250 °C; 1H NMR (400 MHz, CDCl3, 298 K): δ 9.06 
(broad, COOH, 3H), 7.16 (overlapped, ArH, 4H), 6.61 
(overlapped, ArH, 4H), 4.86 – 4.75 (overlapped, ArCH2Ar + 
OCH2COOH, 6H), 4.56 (broad s, OCH2COOH, 2H), 4.28 (d, J 
= 12.8 Hz, ArCH2Ar, 2H), 3.79 (s, OCH3, 3H), 3.28 – 3.21 
(overlapped, ArCH2Ar, 4H), 1.32 (s, C(CH3)3, 18H), 0.85 (s, 
C(CH3)3, 18H). 13C NMR (100 MHz, CDCl3, 298 K): δ 173.4, 
171.0, 151.0, 149.7, 147.0, 146.3, 145.8, 134.5, 134.1, 132.9, 
131.9, 131.7, 125.9, 125.8, 125.4, 125.2, 72.0, 71.7, 63.3, 34.0, 
33.6, 31.5, 31.3, 31.2, 30.9, 30.9, 30.5. HRMS (ESI+) m/z [M + 














Figure 72. HR-ESI (+) MS spectrum of derivative 19. 
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6.2.8. Synthesis of Derivative 35. 
To a stirred solution of amine 34 (198 mg, 0.809 mmol) in 
CH2Cl2 (3 mL) at 0 °C under nitrogen atmosphere was added 
dropwise a solution of isothiocianate 33 (492 mg, 0.809 mmol, 
1 eq) in CH2Cl2 (3 mL). The resulting mixture was stirred at RT 
for 48 h, than the solvent was removed under reduced pressure 
and the crude product was purified by flash cromatography on 
silica gel with CH2Cl2/Et2O (1:0 to 99:1) eluent to afford 
compound 35. Pale brown solid; 60% yield (431 mg); mp 146–
150 °C; [α]D
20 = - 51.79 ± 0.09 (c = 1.00, CHCl3 ); 1H NMR 
(600 MHz, CDCl3, 298 K): δ 7.85 (m, 2H, ArH), 7.74 (m, 2H, 
ArH), 6.94–6.92 (overlapped, 2H, ArH), 6.87 (d, J = 6.2 Hz, 1H, 
ArH), 6.81 (t, J = 7.4 Hz, 1H, ArH), 6.66–6.62 (overlapped, 3H, 
ArH, NH), 6.35 (t, J = 7.4 Hz, 1H, ArH), 6.27 (d, J = 7.2 Hz, 
1H, ArH)  6.24 (d, J = 7.2 Hz, 1H, ArH), 6.03 (s, 1H, ArH), 5.77 
(s, 1H, ArH), 5.35 (d, J = 9.0 Hz, 1H, NH), 4.97 (m, 1H, 
CH2CH2CHN), 4.45–4.39 (overlapped, 4H, ArCH2Ar), 3.95–
3.80 (overlapped, 7H, OCH2CH2CH3, CH2CH2CHN), 3.70 (t, J 
= 7,0 Hz, 2H, OCH2CH2CH3), 3.17–3.05 (overlapped, 4H, 
ArCH2Ar), 2.54 (m, 1H, CH2CH2CHN), 2.25 (m, 1H, 
CH2CH2CHN), 1.95–1.84 (overlapped, 9H, OCH2CH2CH3, 
CH2CH2CHN), 1.78–1.74 (overlapped, 2H, CH2CH2CHN, 
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CH2CH2CHN), 1.49 (m, 1H, CH2CH2CHN), 1.28 (m, 1H, 
CH2CH2CHN), 1.10 (t, J = 7.4 Hz, 3H, OCH2CH2CH3), 1.04 
(overlapped, 4H, OCH2CH2CH3, CH2CH2CHN) 0.93–0.90, 
(overlapped, 6H, OCH2CH2CH3); 13C NMR (150 MHz, CDCl3, 
298 K): δ 179.9, 168.5, 157.4, 157.3, 156.8, 156.0, 155.4, 136.6, 
136.5, 136.3, 135.6, 135.5, 135.3, 134.1, 134.0, 133.97, 129.1, 
128.9, 128.7, 128.5, 128.2, 128.17, 128.0, 127.8, 125.2, 124.7, 
123.4, 122.4, 122.2, 121.9, 121.4, 115.5, 76.75, 76.71, 76.69, 
55.4, 54.2, 33.1, 31.1, 31.05, 31.0, 28.8, 25.5, 24.5, 23.6, 23.5, 
23.2, 10.8, 10.7, 10.1; HRMS (ESI+)  calcd for C55H64N3O6S [M 























6.2.9. Synthesis of Derivative 16. 
A solution of compound 35 (416 mg, 0.465 mmol), and 
NH2NH2·H2O (0.6 mL) in ethanol (7 mL) was heated to reflux 
for 2 h, then the solvent was removed under reduced pressure. 
The crude product was suspended in CH2Cl2 (10 mL) and 
washed with water (2x10 mL). The aqueous layer was extracted 
with CH2Cl2 (10 mL). The collected organic layers were dried 
over Na2SO4, filtered and evaporated under reduced pressure. 
The product 16 was precipitated from CH3CN and recovered by 
filtration. White solid; 52% yield (186 mg); mp  95–97 °C; [α]D
20 
= + 2.9 ± 0.2 (c = 1.00, CHCl3 ); 1H NMR (600 MHz, CDCl3, 
298 K): δ 7.07–6.68 (overlapped, 7H, ArH, NH), 6.45–6.34 
(overlapped, 3H, ArH), 6.09 (broad, 2H, ArH), 5.60 (broad, 1H, 
NH), 4.44–4.42 (overlapped, 4H, ArCH2Ar) 4.09 (broad, 1H, 
CH2CH2CHN), 3.95–3.88 (overlapped, 4H, OCH2CH2CH3), 
3.76–3.71 (overlapped, 4H, OCH2CH2CH3), 3.17–3.09 
(overlapped, 4H, ArCH2Ar), 2.37 (broad, 1H, CH2CH2CHN), 
2.04–1.99 (overlapped, 2H, CH2CH2CHN), 1.93–1.86 
(overlapped, 8H, OCH2CH2CH3), 1.73–1.69 (overlapped, 2H,  
CH2CH2CHN), 1.34–1.19 (overlapped, 4H, CH2CH2CHN), 
1.07–1.03 (overlapped, 6H, OCH2CH2CH3), 0.92–0.90, 
(overlapped, 6H, OCH2CH2CH3); 13C NMR (150 MHz, CDCl3, 
154 
298 K): δ 180.2, 157.4, 156.1, 155.0, 136.6, 136.4, 135.5, 134.2, 
129.2, 128.5, 128.4, 127.9, 127.87, 124.1, 123.8, 122.4, 121.6, 
76.72, 61.7, 55.9, 34.9, 32.1, 31.2, 31.1, 31.08, 29.8, 25.1, 25.0, 
23.5, 23.2, 10.7, 10.68, 10.1; HRMS (ESI+) calcd for 
C47H62N3O4S [M + H]























6.2.10. Synthesis of Derivative 31a. 
A solution of compound 38 (200 mg, 0.488 mmol), and 
NH2NH2·H2O (0.63 mL) in ethanol (4 mL) was heated to reflux 
for 2 h, then the solvent was removed under reduced pressure. 
The crude product was suspended in CH2Cl2 (10 mL) and 
washed with water (2x10 mL). The aqueous layer was extracted 
with CH2Cl2 (10 mL). The collected organic layers were dried 
over Na2SO4, filtered and evaporated under reduced pressure. 
The product 31a was precipitated from CH3CN and recovered 
by filtration. White solid; 76% yield (103 mg); mp 144-145 °C; 
[α]D
20 = + 34.9 ± 0.7 (c = 1.00, CHCl3); 1H NMR (400 MHz, 
CDCl3, 298 K): δ 8.04 (br, 1H, NH), 7.21–7.19 (overlapped, 2H, 
ArH), 6.93–6.91 (overlapped, 2H, ArH), 5.92 (broad, 1H, NH), 
4.13 (broad, 1H, CH2CH2CHN), 3.81 (s, 3H, OCH3), 2.42 
(broad, 1H, CH2CH2CHN), 2.12 (m, 1H, CH2CH2CHN), 1.93 
(m, 1H, CH2CH2CHN), 1.72–1.70 (overlapped, 2H, 
CH2CH2CHN), 1.35–1.21 (overlapped, 4H, CH2CH2CHN); 13C 
NMR (100 MHz, CDCl3, 298 K): δ 181.5, 158.7, 127.4, 115.2, 
62.0, 56.0, 55.7, 35.5, 32.2, 25.0, 25.0; HRMS (ESI+) calcd for 
C14H22N3OS [M + H]














Figure 83. HR-ESI (+) MS spectrum of derivative 31a. 
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6.3. Preparation of Complexes and Ka Determination 
 
6.3.1. General Procedure for the Preparation of Na+⸦X (X 
= 9, 12, 13 and 15) Complexes.  
Calixarene-amide derivative (1 mmol) and sodium TFPB 
salt (1 mmol) were dissolved in CDCl3 (0.5 mL). Each solution 
was sonicated at room temperature for 15 min and then 
transferred into an NMR tube for 1D and 2D NMR spectra 
acquisition. The Ka values were determined by integration of 
1H 
NMR signals of free and complexed host. 
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6.3.2. Determination of Na+⸦X (X = 9 and 15) Ka Value 
 
6.3.3. Determination of Na+⸦12 Ka Value 
Ka value of the Na
+⸦12 complex was determined via 1H 
NMR competition experiments, performed by analysis of a 1:1:1 
mixture of NaTFPB (1 mmol), 12 (1 mmol) and 15 (1 mmol) in 









Figure 84. 1H NMR spectra (400 MHz, CDCl3, 298 K) of: (a) derivative 9; (b) an equimolar 
solution (1.9 mM) of 9 and NaTFPB after mixing; (c) an equimolar solution (1.9 mM) of 9 









Figure 85. HSQC Spectrum (600 MHz, CDCl3, 298 K) of 
an equimolar solution (1.9 mM) of 9 and NaTFPB after 
equilibration for 3 d at 298 K. 
 
Figure 86. Section of  the HSQC 
spectrum (600 MHz, CDCl3, 298 
K) in figure 82. 
 
 






Figure 87. 1H NMR spectrum (400 MHz, CDCl3, 298 K) of a 1:1 mixture of 9 (1.9×10
-3 M) and NaTFPB 
(1.9×10-3 M). The association constant Ka value was calculated by integration of complexed ArCH2Ar (▲) 
and free ArCH2Ar (●) signals of host 9. Ka = (1/1.22×1.9×10






Figure 88. 1H NMR spectra (400 MHz, CDCl3, 298 K) of: (a) derivative 12; (b) an equimolar 
solution (1.9 mM) of 12 and NaTFPB after mixing; (c) an equimolar solution (1.9 mM) of 12 








Figure 89. 2D COSY-45 spectrum (600 MHz, CDCl3, 
298 K) of an  equimolar solution (1.9 mM) of 12 and 
NaTFPB after equilibration  for 3 d (72 h) at 298 K. 
 
 
Figure 90. Section of the 2D COSY-




Figure 91. HSQC Spectrum (600 MHz, CDCl3, 298 
K) of an equimolar solution (1.9 mM) of 12 and 
NaTFPB after equilibration for 3 d (72 h) at 298 K. 
 
Figure 92. Section of the HSQC 





Figure 93. 1H NMR spectra (400 MHz, CDCl3, 298 K) of: (a) an equimolar solution (1.9 mM) of 15 and NaTFPB after equilibration 
for 3 days at 298 K; (b) an equimolar solution (1.9 mM) of NaTFPB, 15 and 12 after equilibration for 3 days; (c) an equimolar solution (1.9 
mM) of 12 and NaTFPB after equilibration for 3 days at 298 K; (d) section of the  1H NMR spectrum of an equimolar solution (1.9 mM) of 
NaTFPB, 15 and 12 after equilibration for 3 days. The association constant Ka value was calculated by integration of complexed OCH3 











Figure 94. 1H NMR spectra (400 MHz, CDCl3, 298 K) of: (a) derivative 13; (b) an equimolar 
solution (1.9 mM) of 13 and NaTFPB after mixing; (c) an equimolar solution (1.9 mM) of 13 








Figure 95. 2D COSY-45 spectrum (400 MHz, CDCl3, 




Figure 96. Section of the 2D COSY-45 
spectrum in figure 92. 
 











Figure 97. HSQC Spectrum (600 MHz, CDCl3, 298 
K) of the Na+ 13cone and Na+ 13paco complexes. 
 
 
Figure 98. Section of the HSQC 
spectrum in figure 94. 
 






Figure 99. 1H NMR spectra (400 MHz, CDCl3, 298 K) of: (a) derivative 15; (b) an equimolar 
solution (1.9 mM) of 15 and NaTFPB after mixing; (c) an equimolar solution (1.9 mM) of 15 









Figure 100. 1H NMR spectrum (400 MHz, CDCl3, 298 K) of a 1:1 mixture of 15 (1.9×10
-3 M) 
and NaTFPB (1.9×10-3 M ). The association constant Ka value was calculated by integration 
of complexed OCH3 (▲) and free OCH3 (●) signals of host 15. Ka = (1/1.28×1.9×10
-




6.3.4. Synthesis of the complex 17(Zr-O-tBu)2 
A solution of Zr(OtBu)4 (0.27 g, 0.71 mmol) in THF (3 mL) 
was added to a stirred solution of proligand 17H6 (0.50 g, 0.36 
mmol) in THF (5 mL) at room temperature. The resulting yellow 
solution was stirred for 30 minutes after which the volatiles were 
removed in vacuum. The residue was washed with pentane 





Figure 101. 1H NMR spectrum of 17(Zr-O-tBu)2 at 25 °C 




Figure 102. 1H-1H COSY spectrum (600 MHz, pyridine-d5, 
90°C) of 17(Zr-O-tBu)2 (a) with magnifications of the 




Figure 103. 1H-13C HSQC spectrum (600 MHz, pyridine-d5, 
25°C) of the complex 17(Zr-O-tBu)2 (a) with magnifications 




Figure 104. 1H-1H NOESY spectrum (600 MHz, pyridine-
d5, 90°C) of the complex 17(Zr-O-
tBu)2 (a) with 




Figure 105. DEPT135 (a) and 13C NMR (b) spectra (600 
MHz, pyridine-d5, 90°C) of the complex 17(Zr-O-
tBu)2. 
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6.4. Catalytic conditions 
 
6.4.1. General Procedure for the Phase-Transfer 
Alkylation of N-(Diphenylmethylene)glycine tert-Butyl 
Ester (14) Catalyzed by Chiral Calixarene-Amide 12.  
To a solution of N-(diphenylmethylene)glycinetert-butyl 
ester 22 (148 mg, 0.50 mmol) and chiral catalyst 12 (28.8 mg, 
0.025 mmol) in mesitylene (5.0 mL) under an inert gas, alkyl 
bromide (1.2–1.5 equiv.) was added. The mixture was degassed 
and then cooled to 0 °C. Degassed aqueous NaOH (50 %, 0.5 
mL)was then added. The reaction mixture was stirred at 0 °C 
until TLC disappearance of the starting material. Then the 
suspension was diluted with CH2Cl2 (25 mL) and water (15 mL), 
and the organic layer was taken. The aqueous layer was 
extracted with CH2Cl2 (2 ×25 mL), and the combined organic 
phases were dried with Na2SO4,filtered, and concentrated in 
vacuo. Purification of the residue by flash column 
chromatography with silica gel (petroleum ether/ethyl acetate, 




6.4.2. General Procedure for Catalytic Enantioselective 
Michael Reaction of Isobutyraldehyde with Maleimide in 
Water.  
To a suspension of N-phenylmaleimide (17.3 mg, 0.1 mmol) 
and catalyst 16 (11.5 mg, 0.015 mmol) in water (200 µL) 
isobutyraldehyde (36 µL, 0.4 mmol) was added and the 
suspension was stirred vigorously at room temperature for 40 
minutes. The crude compound 39 was purified by flash 
chromatography (eluting from PE/ ethyl acetate 9:1 to 7:3). 
 
6.4.3. General Procedure for Solvent-free Catalytic 
Enantioselective Michael Reaction of Isobutyraldehyde 
with Maleimide.  
A sample vial was charged with N-phenylmaleimide (17.3 
mg, 0.1 mmol), catalyst 16 (11.5 mg, 0.015 mmol) and finally 
the isobutyraldehyde (36 µL, 0.4 mmol). The reaction mixture 
was stirred at room temperature until completion, monitored by 
TLC (eluent PE/ ethyl acetate 7:3). The crude compound 39 was 
purified by flash chromatography (eluting from PE/ ethyl acetate 




6.4.4. Catalytic Asymmetric Solvent-free Michael Addition 
of Isobutyraldehyde to Nitroolefins.  
The nitroolefin (0.1 mmol), catalyst 16 (11.5 mg, 0.015 
mmol) and finally the isobutyraldehyde (36 µL, 0.4 mmol) were 
loaded in capped vial. The reaction mixture was stirred at room 
temperature until completion, monitored by TLC (eluent PE/ 
ethyl acetate 9:1, visualized by UV light and by p-anisaldehyde 
staining solution). The residue was purified by flash 
chromatography (eluting from PE/ ethyl acetate 100:1 to 9:1). 
 
6.4.5. Catalytic Enantioselective Solvent-free Addition of 
Dimethyl Malonate to Benzylideneacetone.  
A sample vial was charged with benzylideneacetone (14.6 
mg, 0.1 mmol), catalyst 16 (11.5 mg, 0.015 mmol) and benzoic 
acid (0.9 mg, 0.0075 mmol). At the end dimethyl malonate (46 
µL, 0.4 mmol) was added and the reaction mixture was stirred 
at room temperature until completion, monitored by TLC (eluent 
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